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ABSTRACT 
 
Insulin has both metabolic and mitogenic effects in several mammalian 
cell types. The pleiotropic effects of insulin include cellular growth and 
glucose uptake. These events are regulated by multiple signals generated by 
the insulin receptor. Insulin stimulates glucose influx and metabolism in 
muscle and liver cells through the Akt pathway, and induces cell proliferation 
through Erk activation. Insulin receptor regulates its own signal in target 
tissues through a negative feedback loop involving the phosphorylation of the 
Insulin Receptor Substrate 1 (IRS1) at serine 612, thus preventing the binding 
of the PI3K regulatory subunit p85, and the subsequent activation of the Akt 
pathway. By this mechanism, insulin-stimulated glucose uptake is down-
regulated. 
The calcium calmodulin-dependent kinase II (CaMKII) controls Ras/Erk 
signalling cascade in response to cell adhesion to extracellular matrix. In order 
to evaluate whether this role of CaMKII is a general phenomenon, I 
investigated its role in insulin signalling. As a cell model I selected a rat 
skeletal muscle cell line (L6) and a primary culture of human fibroblasts. 
Insulin stimulation generated partly independent signals leading to the 
activation of PI3K/Akt and Ras/ERK1/2 cascades. Furthermore, an increase in 
[Ca2+]i  and CaMKII activation were observed following insulin stimulation in 
both cell types. In order to investigate the role of CaMKII in insulin 
signalling, I evaluated the effect of CaMKII inhibition on individual pathways 
generated by insulin stimulation. CaMKII inhibition was achieved by KN93 (a 
specific CaMKs pharmacological inhibitor), antCaNtide (CaMKII specific 
inhibitory cell-permeant peptide) or by infection with a CaMKII dominant 
negative recombinant adenovirus. 
CaMKII inhibition abrogated insulin induced Erk1/2 activation and 
thymidine incorporation. Insulin promoted CaMKII association with Raf-1, 
and this binding was dependent upon CaMKII activity, suggesting  that the 
interaction  between CaMKII and Ras/Erk pathway occurred on Raf1. 
Following insulin stimulation Erk phosphorylates IRS1 at Ser 612. This 
mechanism represents a negative feedback loop by which Insulin down 
regulates its own stimulation of glucose uptake.  I investigated the role of 
CaMKII in this negative feedback by analysing the effects of CaMKII 
inhibitors on  PI3K/Akt pathway. KN93 and antCaNtide prevented insulin 
induced phosphorylation of IRS1 at Ser 612 by Erk, and prolong the binding 
of p85 to IRS1. Inhibition of CaMKII abrogated the down-regulation of 
insulin-stimulated Akt phosphorylation, GLUT-4  translocation  to the plasma 
membrane and glucose uptake. 
These results demonstrate that: 1-CaMKII mediates the insulin-induced 
Erk-1/2 activation and cell proliferation, 2-CaMKII mediates the 
downregulation of glucose uptake by inhibiting PI3K/Akt pathway. This 
represents a novel mechanism in the selective control of insulin signals, and a 
possible novel site for pharmacological intervention. 
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1. BACKGROUND 
 
1.1 The Ca2+/Calmodulin dependent Kinases (CaMKs) 
 
Calcium (Ca2+) is a universal second messenger in eukaryotic cells. Changes 
in intracellular Ca2+ concentration play a major role in a broad array of cell 
functions including transcription, cell cycle, apoptosis, exocytosis, protein 
synthesis and motility, often having multiple roles within a single cell 
(Anderson and Kane, 1998). Cells typically maintain an intracellular Ca2+ 
level of 10-7 M, which is 104 times lower than the level outside the cell, by 
sequestering Ca2+  in several intracellular organelles (Hudmon and Schulman, 
2002). Cells have an intricate network by which they accurately control 
cytoplasmic Ca2+  level. ATP dependent Ca2+  pumps shuttle Ca2+  into the 
two major  Ca2+ sinks, the endoplasmic reticulum (ER) and the extracellular 
space (Hook Sara S, 2001). Various signals stimulate either waves or spikes of 
increased intracellular Ca2+ up to a concentration  of 10-4M. The source of  
Ca2+ depends on the stimulus. Tyrosine kinases receptors and G-protein 
coupled receptors classically increase Ca2+  concentration levels by producing 
inositol 1,4,5 triphosphate (IP3), which induces  Ca2+ release from the ER via 
IP3 receptor (Berridge, 1993). Similarly, Cyclic ADP ribose can release Ca2+  
from intracellular stores. Ligand gated ion channels and voltage dependent ion 
channels in the plasma membrane initiate  Ca2+ entry via extracellular stores. 
The predominant intracellular receptor for  Ca2+ is Calmodulin (CaM), a 
small, highly conserved Ca2+ sensor that is ubiquitously expressed in 
mammalian cells (Bito, 1998). CaM serves as a receptor to sense changes in  
Ca2+ concentration and, in this way, mediates the second messenger role of 
these ion.  Ca2+ binds to CaM by a structural motif called EF-hand, and a pair 
of these structures are located in both globular ends of the protein. When the 
four binding sites are filled, CaM undergoes a conformational change exposing 
a flexible eight-turn α helix, which separates the hydrophobic pockets present 
at each  globular end of the protein. CaM thus become “loaded” with Ca2+ and 
capable to interact with one of its many target proteins in the cell. The 
interaction with target proteins, while usually of high affinity, is rapidly 
reversible upon a decline in Ca2+ concentration (Means, 2000). One of the 
major family of Ca2+/CaM effectors is represented by the Ca2+/CaM dependent 
protein kinases (CaMKs) which can be divided into dedicated CaMKs that 
phosphorylate a single specific substrate such as myosin light chain kinase 
(MLCK) and the multifunctional CaMKs including CaMKI, CaMKII and 
CaMKIV, that phosphorylate a large number of proteins (Braun and Schulman, 
1995).  
 CaMKs exhibit fascinating regulatory properties. Their structure presents 
a  regulatory portion  containing an autoinhibitory domain interacting with the 
catalytic domain and keeping the enzyme inactive at resting calcium levels. 
According to this “intrasteric inhibition model” (Cruzalegui et al., 1992), 
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Ca2+/CaM binding to a region adjacent to the autoinhibitory domain causes a 
change in conformation that allows access of substrate and ATP to the catalytic 
domain. Thus the CaMK can rapidly sense elevation in intracellular Ca2+, 
becoming active following Ca2+/CaM binding. Moreover, some of these 
enzymes are also equipped with mechanism enabling them to prolong their 
activity after Ca2+  has returned to basal levels. This “molecular memory” is 
documented for CaMKII, a multimeric enzyme composed of 8-12 subunits. 
Each subunits is a 50/60 kDa polypeptide containing a N-terminal catalytic 
domain, a central autoinhibitory and CaM binding region and a C-terminal 
domain responsible for multimerization and intracellular localization. A 
linearized diagram for the domain structure of CaMKII is shown in Figure 1.1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 The unique multimeric structure of CaMKII allows very rapid trans-
phosphorylation of subunits within the complex. As a consequence of trans-
phosphorylation on Ser 286, a subunit acquires Ca2+/CaM independent activity 
(Miller and Kennedy, 1986). In addition, the affinity of the autophosphorylated 
subunits for CaM increases, making it more sensitive to further Ca2+ elevation 
(Anderson and Kane, 1998) . These properties of CaMKII allow the enzyme to 
remain active for some time after Ca2+  levels have dropped below the 
activation threshold, which explains why CaMKII activity is stimulated not 
only by sustained increases in Ca2+  concentration but also by Ca2+  oscillations 
(De Koninck and Schulman, 1998). The activity of CaMKI and CaMKIV, 
which act as monomeric enzymes, is also modulated by phosphorylation. 
However, in contrast to CaMKII, the regulatory phosphorylation events are 
catalysed by a distinct group of Kinases termed CaM Kinase kinases (CaMKK) 
(Soderling, 1999). CaMKKs themselves are Ca2+ /CaM dependent enzymes. 
They phosphorylate Ca2+ /CaM-bound CaMKI and CAMKIV on a Thr residue 
Figure 1.1  Linear diagram of a prototypical CaMKII subunit
 
The catalytic domain is autoinhibited by a pseudosubstate autoregulatory sequence that is 
disinhibited following Ca2+/CaM binding. The association domain produces the native form 
of the enzyme, a multimeric holoenzyme composed of 8-12 subunits. Isoform differences 
present in α, β, γ, and δ isoforms of CaMKII are contributed primarily by a region of multiple 
alternatively spliced sequences, termed variable inserts, which reside in the association 
domain. Conserved sites of autophosphorylation are indicated in the autoregulatory region 
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situated within the activation loop. These phosphorylation events cause the 
activity of CaMKI and CaMKIV to increase several folds (Chatila et al., 1996).  
Apart from the activation features, CaMKs differ in tissue and subcellular 
localization. CaMKII and CaMKI are ubiquitously expressed, while CaMKIV 
is tissue specific and expressed mainly in brain, thymus, testis, ovary, bone 
marrow and adrenal gland (Wang et al., 2001). While CaMKIV is 
predominantly nuclear (Jensen KF, 1991) and CaMKI appears to be a cytosolic 
enzyme (Picciotto MR, 1996), the subcellular distribution of CaMKII can vary 
(Heist and Schulman, 1998). Some of the comparative properties of CaMKI, 
CaMKII and CaMKIV are listed in Table 1. 
Four types of subunits of CaMKII have been identified (α, β, γ, δ) that are 
encoded by different genes with differing tissue-specific expression. 
Alternative splicing within the C-terminal sequence of each gene produces 
further isoforms. Although the biochemical characteristics of CaMKII purified 
from many tissues are practically identical, the subunit composition, that is 
dependent on the source, seems to determine the subcellular localization of the 
complex. The most studied forms  of CaMKII in the nervous system are rich in 
α and β subunits, and are mainly cytoplasmic enzymes. Some splice variants of 
the α, γ and δ CaMKII genes contain a nuclear localization signal (NLS) 
(Brocke et al., 1995; Srinivasan et al., 1994), resulting in targeting of the kinase 
to the nucleus. Expression of the δ isoform together with cytoplasmic isoforms 
of CaMKII can direct the heteromultimeric enzyme complex to the nucleus, 
suggesting that the relative abundance of cytoplasmic or nuclear-targeted 
subunits may determine the subcellular localization (Heist et al., 1998). The 
nuclear entry of CaMKII can also be regulated by other kinases. In all 
mammalian nuclear CaMKII isoforms, the NLS is followed by a string of four 
Ser residues. Phosphorylation of the four Ser by CaMKI or CaMKIV blocks 
both nuclear translocation of α subunit and binding to importin.(Griffith et al., 
2003) . Another peculiarity of CaMKII is its association into a multimeric 
complex. The enzyme homomultimerizes through the association domain to 
form a holoenzyme of 8-12 subunits. Within the regulatory domain are 
overlapping autoinhibitory and CaM-binding domain. In the absence of Ca2+ 
/CaM, CaMKII is inhibited intrasterically by the autoinhibitory region, which 
is believed to prevent both substrate and ATP from binding to the enzyme. The 
binding of Ca2+/CaM relieves the autoinhibitory domain thus leading  to de-
inhibition of the kinase. 
Once activated by Ca2+/CaM, CaMKII autophosphorylates on Thr286 
located in the regulatory domain. This event has two important consequences: 
first, the affinity of the enzyme for Ca2+/CaM is increased in a process called 
“CaM trapping”; Second, the autoinhibitory domain is further disrupted 
making CaMKII partially independent of Ca2+ /CaM or “autonomous” 
Autophosphorylation occurs between two neighboring subunits in one 
holoenzyme through an intersubunit reaction (Hudmon and Schulman, 2002) 
(Figure 1.2). 
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TABLE. 1.1: Properties of the multifunctional Ca2+/CaM dependent protein kinases 
 
 
 
 CaMKI CaMKIV CaMKII 
Tissue 
distribution 
Ubiquitous Limited to: 
brain, thymus, 
testis, ovary, 
bone marrow 
and adrenal 
gland 
Ubiquitous 
Subcellular 
localization 
Cytoplasmic Nuclear and 
Cytoplasmic 
Cytoplasmic, 
except 
αΒ , γΑ , δΒ forms 
can be nuclear 
Subunit 
composition 
Monomeric Monomeric Homo- or 
heteromultimeric
Known 
requirement 
for complete 
activation 
Ca2+/CaM 
binding, 
activation loop 
phosphorylation
Ca2+/CaM 
binding, auto-
phosphorylation, 
activation loop 
phosphorylation
Ca2+/CaM 
binding 
Gains 
Ca2+/CaM 
independence 
No Yes (up to 20% 
of Ca2+/CaM 
dependent 
activity) 
Yes (with auto-
phosphorylation; 
up to 80% 
Ca2+/CaM-
dependent 
activity) 
Inhibition by 
KN93 (KI) 
0,8 μM 3 μM 0,8 μM 
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CaMKII exerts a broad range of biological functions  such as regulation of 
gene expression, cell cycle, proliferation and a number of neuronal  functions. 
CaMKII is one of the most abundant proteins in the brain, comprising 1% of 
the total proteins in the forebrain and 2% in the hippocampus, a region 
associated with memory. The first of the CaMKII isoforms to be identified, 
CaMKIIα is a major component of the postsynaptic membrane (PSD) in 
pyramidal neurons. In the PSD, CaMKII is thought to increase synaptic 
strength by phosphorylating ion channels and signalling proteins such as 
glutamate receptors and N-metyl D-aspartate (NMDA) receptors.(Cruzalegui 
and Bading, 2000).  
 
 
 
 
 
 
 
 
 
Figure 1.2 Ca2+/CaM-dependent Kinase II activation
 
Clockwise from the top: CaM undergoes a conformational change upon Ca2+ binding. 
Ca2+/CaM docks at hydrophobic site adjacent to the autoinhibitory domain of a CaMKII 
subunit. Stepwise activation, potentiation and inactivation of CaMKII are represented 
schematically in blue.(Means A. R. 2000) 
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In hippocampal neurons, it has been suggested that stimulation of the 
NMDA receptors regulates association of CaMKII between the F-actin and the 
PSD in a dynamic manner. Thus, CaMKII is involved both in the mainteinance 
of dendritic architecture  and synaptic plasticity. In addiction CaMKII is 
required for long lasting changes in synaptic strength such as long-term 
potentiation (LTP), a process involved in learning and memory (Giese et al., 
1998). As a result, modulatory changes in CaMKII have been hypothesized to 
be implicated in human pathologies of memory including Alzheimer Dementia 
and Angelman’s mental retardation. However, CaMKII has several modulating 
roles in the neuron in addition to LTP induction, including presynaptic 
functions such as neurotransmitter synthesis, neurotransmitter secretion, 
microtubule disassembly and post synaptic functions such as phosphorylation 
of a number of proteins and kinases in the postsynaptic density of downstream 
neurons. A list of CaMKII neuronal functions is reported in Figure 1.3  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3 Schematic representation of activation and role of CaMKII in 
neuronal cells. 
 
Intracellular Ca2+ is increased by intracellular stimuli, binds to Calmodulin, and 
activates CaMKII. CaMKII phosphorylates various kinds of proteins and 
regulates physiological processes. (Yamauchi, 2005) 
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Whereas the membrane and cytoskeletal roles of CaMKII are beginning to 
be clarified, the nuclear functions of CaMKII remain obscure. Most of the 
studies that have addressed nuclear functions of CaMKII have relied on the 
ability of C-terminal truncated Ca2+/CaM-independent forms of the enzyme to 
alter transcription when over-expressed in cells along with reporter gene 
constructs. One of the first such paradigms to be examined was the Ca2+ 
stimulation of immediate early genes that are regulated by cAMP response 
element (CRE) such as c-fos. Phosphorylation of CRE binding protein (CREB) 
on Ser133 is essential for transcription because it is required for binding of the 
ubiquitously expressed CREB binding proteins CBP and p300, which function 
as transcriptional cointegrator (De Cesare et al., 1999). Ser-133 was originally 
identified as the target of protein kinase A (PKA), thus explaining the role of 
cAMP in transcriptional activation. However CaMKII can also phosphorylate 
this residue leading to the speculation that CAMKII mediates  Ca2+ 
requirement for expression of the immediate early genes .Thus CREB was 
proposed as a target at which cAMP- and Ca2+-mediated signal transduction  
cascades converge to regulate transcription. However, while the truncated form 
of CaMKII can stimulate CREB-mediated transcription in some cells, it is 
inhibitory in others. Sun at al. (Sun P, 1994) discovered that one mode of 
inhibition was that, in addition to Ser133, CaMKII also phosphorylated a 
second residue on CREB, Ser142. Indeed phosphorylation of Ser142 was not 
only inhibitory, but this modification was also dominant and could reverse the 
activation of CREB resulting from its phosphorylation on Ser133 by PKA. The 
mechanism by which phosphorylation of Ser142 inhibits CREB-mediated 
transcription seems to be by destabilizing the association between CREB and 
CBP (Parker D, 1998). Interestingly, the nature of the effects of CaMKII on 
transcription seems to be both cell and promoter dependent. Whereas CaMKII 
inhibits transcription of the interleukin 2 gene in a human T cell line (Nghiem 
Paul, 2002), it was found to stimulate atrial natriuretic factor (ANF) gene 
expression in ventricular myocites (Ramirez et al., 1997). Regulatory elements 
sensitive to CaMKII include C/EBPβ , CRE, SRE, and AP1 (Means et al., 
1991). A  role for CaMKII in the regulation of cell cycle and cell proliferation 
have also been investigated. Morris et al. demonstrated that CaMKII mediates  
Ca2+/CaM-dependent G1 phase progression in mammalian fibroblasts by 
influencing cyclin D1 levels. Indeed, the inhibition of the endogenous cellular 
CaMKII by KN93 completely prevents DNA synthesis and leads to decreased 
levels of cyclin D1, a critical regulatory molecule of the G1 phase protein 
kinase cdk4 (Morris et al., 1998). 
More recent works show that CaMKII regulates cell proliferation in different 
cell types (An et al., 2007; House et al., 2007; Muthalif et al., 2001) 
Illario et al. demonstrated for the first time that CaMKII is a crucial mediator 
of the Ras/Erk pathway (Illario et al., 2003)  
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In thyroid cells, integrin stimulation by Fibronectin simoutaneously 
activates two signalling pathways: Ras/Raf/Mek/Erk and Ca2+/CaMKII. Both 
signals are necessary to stimulate Erk phosphorylation and cell proliferation as 
inhibition of Ca2+/CaMKII signal pathway by CaM or CaMKII inhibitors 
completely  abolished the fibronectin induced Erk phosphorylation. The 
mechanism by which CaMKII modulates Raf1 activation is not fully 
elucidated. In thyroid cells stimulated by fibronectin, activated CaMKII binds 
to Raf1 . This event appear to be necessary to subsequent Mek/Erk activation. 
(Illario et al., 2005)  
 
 
1.2 The Insulin Signalling Pathway 
Insulin is an anabolic hormone secreted by the β cells of the pancreatic 
islets of Langerhans and it plays a pivotal role in the regulation of glucose 
homeostasis. 
Elevated concentrations of glucose in blood stimulate the release of 
insulin, and insulin action stimulates uptake, utilization and storage of glucose. 
The effects of insulin on glucose metabolism vary depending on the target 
tissue. Two important effects in carbohydrates metabolism are: 
1) Insulin facilitates glucose entry in muscle and adipose tissue  
The vast majority of cells take up glucose only by facilitated diffusion though a 
family of hexose transporters. In muscle cells the major transporter used for 
glucose uptake is GLUT-4. In the absence of insulin GLUT-4 glucose 
transporters are present into cytoplasmic vesicles, where they are stored in 
resting conditions. Binding of insulin to its receptors in these cells leads rapidly 
to the fusion of those vesicles with the plasma membrane and to the insertion 
of the glucose transporters , thereby making the cells able to efficiently take up 
glucose. When blood levels of insulin decrease and insulin receptors are no 
longer occupied, the glucose transporters are recycled into the cytoplasm 
(Pessin et al., 1999). 
2) Insulin induces glucose storing as glycogen in the liver 
Insulin activates the enzyme hexokinase, which phosphorylates glucose, 
trapping it within the cell. In the meantime insulin acts to inhibit the activity of 
glucose-6-phosphatase. Insulin also activates several enzymes that are directly 
involved in glycogen synthesis, including phospho-fructokinese and glycogen 
synthase (Pilkis and Granner, 1992; Sutherland et al., 1996). 
 
Insulin has also a pivotal role in the regulation of lipid metabolism. 
Important effects of insulin on lipid metabolism include the following: 
1) Insulin promotes the synthesis of fatty acids in the liver  
As discussed above, insulin stimulates glycogen synthesis in the liver. 
However, as glycogen accumulates to high levels (roughly 5% of liver mass), 
further synthesis is strongly suppressed. When the liver is saturated with 
glycogen, any additional glucose taken up by hepatocytes is shunted into 
pathways leading to synthesis of fatty acids, which are exported from the liver 
 16
as lipoproteins. The lipoproteins are ripped apart in the circulation, providing 
free fatty acids for other tissues, including adipocytes, which use them to 
synthesize triglyceride 
2) Insulin inhibits breakdown of fat in adipose tissue 
Insulin inhibits the intracellular lipase that hydrolyzes triglycerides to release 
fatty acids. Insulin facilitates entry of glucose into adipocytes and, within those 
cells, glucose can be used to synthesize glycerol. This glycerol, along with the 
fatty acids delivered from the liver, is used to synthesize triglyceride. By these 
mechanisms, insulin is involved in further accumulation of triglyceride in fat 
cells (Saltiel and Kahn, 2001). 
Besides being the most potent anabolic hormone, Insulin is essential for 
appropriate tissue development, growth and maintenance of whole-body 
glucose homeostasis. Insulin induces both mitogenic and metabolic effects in 
most cell type and it can initiate both immediate and long-term cellular 
responses. The immediate effects of this hormone include an increase in the 
rate of glucose uptake from the blood into muscle cells and adipocytes and 
modulation of the activity of various enzymes involved in glucose metabolism. 
These effects occur within minutes, do not require new protein synthesis, and 
occur at insulin concentrations of 10−9 to 10 −10 M. Continued exposure to 
insulin  produces long-lasting effects including increased expression of liver 
enzymes that synthesize glycogen and of adipocyte enzymes that synthesize 
triacylglycerols. Insulin also functions as a growth factor for many cells (e.g., 
fibroblasts). These effects are manifested in hours and require continuous 
exposure to ≈10−8 M insulin. 
The capability of insulin receptor to regulate such different functions 
depends upon its ability to generate a number of different intracellular signals. 
The insulin receptor (IR) is a heterotetrameric protein consisting of two 
extracellular α subunits and two transmembrane β subunits. The binding of 
insulin to the α subunit of IR stimulates the thyrosine kinase activity intrinsic 
to the β subunit of the receptor. Extensive studies have indicated that the ability 
of the receptor to autophosphorylate and phosphorylate intracellular substrates 
is essential for its mediation of the complex cellular responses to insulin. 
Structure biology studies revealed that the two α subunits are in a juxtaposition 
that permits autophosphorylation of thyrosine residues, the first step of Insulin 
receptor activation. The kinase domain undergoes conformational change upon 
auto-phosphorylation, providing a basis for activation of the kinase and binding 
of downstream signalling molecules (Patti and Kahn, 1998). 
At the proximal level, phosphorylation of the Insulin receptor Substrates (IRSs) 
represent one of the earliest events involved in the insulin signalling(White and 
Kahn, 1994). 
The four IRS proteins identified (IRS 1-4) to date are highly homologous 
with overlapping and differential tissue distribution. Studies with genetic 
deletion in mouse models and cell lines indicate that these proteins serve 
complementary functions in different tissues as immediate substrates for 
Insulin and IGF1 receptors. IRS1 knockout mice exhibit growth retardation due 
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to resistance to insulin and IGF1, β cell hyperplasia and impaired glucose 
tolerance(Taylor, 1992). IRS2 knockout mice exhibit more severe insulin 
resistance in the liver and peripheral tissues, and develop overt type 2  diabetes 
as a result of profound insulin resistance combined with impaired β cell 
function(Wojtaszewski et al., 1999). Combined heterozygous deletions of 
insulin receptor, IRS1 and IRS2 in different tissues results in insulin resistance 
in skeletal muscle and liver and marked β cell hyperplasia. These data indicate 
tissue specific differences in the roles of IRSs proteins to mediate insulin 
action, with IRS1 playing a prominent role in skeletal muscle and IRS2 in liver 
(Nandi et al., 2004). 
  IRS1 possesses multiple thyrosine phosphorylaton residues, which allow it 
to interact with other signalling molecules containing SH2 domains such as 
Grb2, Syp, Nck, and two isoforms of the regulatory subunit of  
phosphoinositide 3 kinase (PI3K)(Lee and Pilch, 1994) (Pessin and Saltiel, 
2000) 
PI3K is a heterodimeric enzyme consisting of the p85 regulatory subunit and 
the p110 catalytic subunit responsible for its lipid kinase activity. Binding of 
the regulatory subunit of PI3K, p85, to thyrosine-phosphorilated IRS1 leads to 
a 3-5 fold stimulation of PI3K activity (Rordorf-Nikolic et al., 1995) and to an 
increase in the PI 3,4 bisphosphate and 3,4,5 trisphosphate in the cells (Kohn et 
al., 1996). Acting as second messengers, these phospholipids recruit the PI3K 
dependent serine-threonine kinases (PDK1) and Akt from the cytoplasm to the 
plasma membrane by binding to the “plekstrin homology domain” (PH 
domain) of the kinases. Lipid binding and membrane translocation lead to 
conformational changes in AKT that is subsequently phosphorylated on the Thr 
308 and Ser 473 by PDK1. Activated AKT phosphorylates and regulates the 
activity of many downstream proteins involved in multiple aspects of cell 
physiology. Among others, AKT phosphorylates and regulates components of 
the glucose transporter 4 (GLUT-4) complex, protein kinase C (PKC) and 
GSK3, all of which are critical in insulin mediated metabolic effects. Insulin-
induced GLUT-4 translocation from the intracellular stores to the plasma 
membrane results in  the increased  glucose uptake in muscle and adipose 
tissue (Kohn et al., 1996).  
IRS1 interaction with other molecules containing SH2 domain such as 
Grb2 and SOS also convey mitogenic signal originating from Ras activation. 
Ras functions as an activator of Raf1, which in turn activates mitogen-activated 
kinase kinase (MEK) and enables phosphorylation and stimulation of MAPK. 
These events are necessary for cell proliferation to occur in response to insulin 
in most cell types (Bandyopadhyay et al., 1997; Nishida and Gotoh, 1993). 
However, there are also evidences that insulin signal can be conveyed into the 
MAPK pathway independently of Ras (Carel et al., 1996; Formisano et al., 
2000). Neither of the three major MAPK signalling cascades namely Erk1/2, 
P38 and jun amino terminal kinase (JNK) promote insulin-mediated metabolic 
responses. Rather, they seem to exert feedback regulatory function. Moreover, 
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an increased basal MAPK activity seems to contribute to the development of 
insulin resistance (Pirola et al., 2004).  
Several studies show that an increase of IRS1 phosphorylation in Ser/Thr 
residues leads to a negative modulation of IRS1 activity. Ser phosphorylation 
of IRS1 can result in subsequent inhibition of its thyrosine phosphorylation by 
the insulin receptor. If the Ser/Thr phosphorylation sites are located in the IRS1 
PTB (phospho thyrosine binding)  domain they may hinder the PTB binding to 
the activated receptor (Aguirre et al., 2000; Aguirre et al., 2002). 
IRS1 contains 4 Ser in the motif Pro-X-Ser-Pro, a consensus sequence 
recognized by members of the MAPK family (Kennelly and Krebs, 1991). All 
of these 4 Ser are located exactly 4 amino acids downstream of potential 
thyrosine phosphorylation sites, and one (Ser 612) is close to the major PI3K 
binding site, thyrosine 608 (Mothe and Van Obberghen, 1996) . 
In CHO cells and in the Human kidney fibroblasts cell line 293, PKC 
activation results in decreased insulin-stimulated IRS1 association with PI3K 
and subsequent AKT/PKB activation. This inhibition was found to correspond 
to the phosphorylation of the Ser 612 of IRS1 by ERK1/2 (Bard-Chapeau et al., 
2005; De Fea and Roth, 1997) . By this mechanism insulin exerts a negative 
feedback on its own stimulation of glucose uptake. Thus, after initial 
stimulation, the glucose entry into the cells is downregulated. 
 A schematic representation of insulin signalling in muscle cells is 
reported in Figure 1.4. 
A more recent study demonstrated, in a model of liver knockout Grb2 
associated binder 1 (Gab1) mice, that Gab1 mediates insulin stimulated 
ERK1/2 activation (Bard-Chapeau et al., 2005). This scaffolding adaptor 
protein, while reducing  insulin-stimulated glucose metabolism in the liver, 
promotes hepatocyte proliferation induced by insulin. Thus, ERK1/2  or Gab1 
modulators can modulate glucose uptake and participate to glucose 
homeostasis. Through this mechanism, insulin-induced effects can be 
modulated by the receptor itself or by endogenous or environmental interfering 
factors. 
In the intricate insulin pathway the role played by Ca2+ has long been 
debated, and it remains still partly unsolved. Indirect evidences suggest that 
Ca2+ is involved in insulin action, as its chelation reduces insulin stimulation of 
glucose uptake (Pershadsingh et al., 1987a).  
Noteworthy, insulin induces an increase in the near-membrane free Ca2+ 
concentration rather than an increase of the cytoplasmic intracellular calcium 
concentration ([Ca2+]i) in skeletal muscle cells. 
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Figure 1.4. Schematic representation of Insulin signalling 
Insulin binds to its receptor leading to the auto-phosphorylation of the β-subunits and the 
tyrosine phosphorylation of insulin receptor substrates (IRS1). IRS1 phosphorylates the 
SH3 domain of the adaptor molecule Grb2. Activated Grb2 recruits Sos that, in turn, 
activates the Ras signalling pathway and cell proliferation. IRS1 also activates 
phosphoinositide 3-kinase (PI3K) through its SH2 domain, thus increasing the 
intracellular concentration of PIP2 and PIP. This, in turn, activates  PDK-1 (not shown), 
that subsequently activates Akt/PKB. This results in the translocation of the glucose 
transporter GLUT-4  from cytoplasmic vesicles to the cell membrane and subsequently 
to glucose uptake. 
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The inhibition of the insulin-induced [Ca2+]i rise in near-membrane  by Ca2+ 
nifedipine and nimodipine suggests that entry of Ca2+ occurs through L-type 
channels (Hofmann et al., 1994). The observation that Wortmannin also 
prevented the Insulin-induced rise in [Ca2+]i (Bruton et al., 1999, 2001) 
suggests that the influx of Ca2+ in the cells occurs via PI3K dependent 
modulation of Ca2+ channels. This could involve phosphorylation of likely 
candidates such as protein kinase A, protein kinase C or calmodulin dependent 
kinases which in turn phosphorylate L-type Ca2+ channels as described in 
neurons and smooth muscle cells (Ahlijanian et al., 1991). The possibility that  
Ca2+ could have biphasic effects on Insulin-stimulated glucose transport was 
examined by Draznin et al (Draznin et al., 1987b). They found that in 
adipocytes, large increases in [Ca2+]i induced by exposure to ionomicin or 
depolarization inhibited insulin stimulated glucose transport, whereas small 
rises in [Ca2+]i were stimulatory. It is feasible that Ca2+  plays a role in the 
docking and insertion of the GLUT-4 transporters into the sarcolemma similar 
to the Ca2+  dependent docking of synaptic vesicles in the nerve terminal 
(Zenisek et al., 2000). Another possibility is that Ca2+  activated Calmodulin 
exerts a modulatory effect at one or more sites in muscle fibre. A role for CaM 
in glucose transport has long been suspected (Shechter, 1984). Inhibition of 
CaM significantly reduces the number of GLUT-4 transporters in the 
sarcolemma after stimulation by insulin or hypoxia. Several studies suggest 
that CaM might be involved either in the movement of vesicles containing 
GLUT-4 transporters to the surface membrane or in the insertion of GLUT-4 
transporters in the sarcolemma (Bruton et al., 2001). All these findings support 
the hypothesis that Ca2+ is an important second messenger in Insulin signaling 
even though its role in the insulin complex signaling network has not been 
clarified in detail. 
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2. AIMS OF THE STUDY 
 
In thyroid cells, CaMKII is activated by cell adhesion to extracellular matrix 
and its binding to Raf1 is necessary to Raf1 activation, thus modulating the 
Ras/Raf/Mek/Erk pathway and cell proliferation (Illario et al. 2005).  
In order to determine whether a cross-talk between CaMKII and Erk 
pathway is restricted to integrins in thyroid cells, or it is a general mechanism 
in the control of cell proliferation, I extended my studies to the signalling 
pathways downstream the insulin receptor. 
Two important and well characterized cell types responding to insulin 
are skeletal muscle cells and fibroblasts. In skeletal muscle cells, insulin 
stimulates proliferation through the Ras/Erk signalling, and glucose uptake 
through PI3K/Akt/GLUT4 cascade. In fibroblasts, insulin effects are mainly 
mitogenic as GLUT-4 is not expressed. 
The aims of this doctorate thesis are to clarify the role of CaMKII 
in insulin-induced mitogenic and metabolic effects in skeletal muscle cells 
and in fibroblasts. 
 To this purpose I investigated: 
1. Whether insulin stimulation modulates the intracellular calcium 
concentration and CaMKII activity; 
2. Whether CaMKII participates to the Ras/Erk signalling and to 
the stimulation of cell proliferation; 
3. Whether CaMKII participates to the PI3K/Akt signalling and 
the modulation of glucose uptake 
 
A rat skeletal muscle cell line (L6) was chosen as a model as it represents a 
typical insulin target tissue. 
This cells have been extensively characterized and they are one of the most 
employed models in the study of insulin effects in skeletal muscle. In order to 
determine if CaMKII involvement in insulin-induced proliferation was a 
general phenomenon, this study was extended to human fibroblasts. 
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3. MATERIALS AND METHODS 
 
3.1 Cell Culture 
The L6 skeletal muscle cells were seeded (5-9 × 103 cells/cm2) and grown 
in Dulbecco's modified Eagle's medium (DMEM) supplemented with 2% fetal 
bovine serum. Under these cultural conditions, the myoblasts reach the 
confluence and then spontaneously differentiate into myotubes. Subsequently 
L6 skeletal muscle cells were grown in Dulbecco modified eagle medium 
(DMEM) (Life Technologies, Inc, Grand Island, NY) supplemented with 10% 
fetal calf serum (Sigma, St. Louis, MO) and 2% glutamine, in a humidified 
CO2 incubator. Human primary fibroblasts were obtained according to the 
procedure described by Postiglione et al. (Postiglione et al., 2005). Briefly, the 
surgical fragments derived from skin biopsies were mechanically dissociated 
and subsequently trypsinized for 30 min at 37°C. After repeated washes with 
PBS, the microfragments were plated and cultured in Dulbecco’s minimal 
essential medium (BioWhittaker, Virviers, Belgium), containing 50% fetal calf 
serum (GIBCO, Grand Island, NY, USA), 200 mM L-glutamine, penicillin 
(100 mg/ml) and streptomycin (100 mg/ml).The plates were incubated at 37°C, 
in the presence of 5% CO2. During the following 10 days  the percent of serum 
was progressively reduced to 10%. After 10 days the cells were maintained in 
culture with DMEM 10% FCS. 
3.2 Calcium Measurements 
 
Fluorimetric analysis: A total of 3x105 cells were harvested by trypsin and 
were loaded with cell-permeant Fura-2 acetoxymethyl ester (Molecular Probes, 
Eugene, OR), by incubating the cells with Dulbecco’s modified Eagle’s 
medium, 10-5 mol/L Fura-2, 0.5% BSA, and 0.01 mol/L HEPES for 30 min at 
37 C. The cells were then washed twice for 10 min with 0.001 mol/L CaCl2 in 
Hanks’ balanced salt solution (0.118 mol/L NaCl, 0.0046 mol/L KCl, 0.01 
mol/L glucose, and 0.02 mol/L HEPES, pH 7.2). Fluorescence was measured 
with a fluorimeter (PerkinElmer Life Sciences). Excitation was at 345 and 380 
nm, emission was at 510 nm. Rmin and Rmax were obtained by adding 0.01 
mol/L EDTA and 2% Triton X-100 or 0.01 mol/L EDTA, 2% Triton X-100, 
and 0.01 mol/L CaCl2, respectively. The nanomolar concentration of Ca2+ was 
obtained by the Grynkiewiez formula considering a 225 KDa for Fura-2 
(Grynkiewicz et al., 1985). 
For calcium transients imaging, 2x105 cells were plated onto a 60 mm 
microscope dish, starved over night, and loaded with 12.5 mg Oregon green, 
100 μl of Standard Buffer (in mM: 137 NaCl; 2.7 KCl; 1 Na2HPO4; 20  Hepes, 
7.4 pH; 1 MgCl2; 2 CaCl2; 2.5 glucose) for 30 min at 37°C. The cells were then 
washed once with Standard Buffer, and acquisition started in 500 μl standard 
buffer. For stimulation, insulin was used at 100 nM final concentration. 
Cytosolic Ca2+ changes were detected using a cooled CCD camera (Coolsnap 
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HQ, Princeton Instruments, Inc., Trenton, NJ) mounted on a Zeiss Axiovert 
200 microscope with a Plan-Neofluar 63 x/1.25 Oil objective. The quantified 
Ca2+  signal was normalized to the baseline fluorescence (F0) following the 
formula Relative fluorescence = [F-F0]/F0, where F represents the average 
fluorescence level of the region of interest at a given time point. Fluorescent 
Ca2+  images were analyzed with the MetaMorph Imaging System software 
(Universal Imaging Corporation, West Chester, PA). 
 
3.3 Western blot and immunoprecipitation procedures 
 
Cells were washed in PBS buffer and lysed on ice for 30 min in RIPA 
buffer (50 mM Tris-HCl, pH 7.4,150 mM NaCl, 1% NP-40,2 mM EDTA,2 
mM PMSF, 5 ug/mL leupeptin, 5 ug/mL pepstatin).The lysate were quantified 
by Biorad DC protein assay. An equal amount of proteins from each sample 
was loaded with laemly buffer. Protein were resolved by SDS-PAGE and 
transferred to an Immobilion P membrane (Millipore Corporation, Bedford, 
MA). Membranes were blocked by incubation with PBS 0,2% tween , 5% 
nonfat dry milk  for one hour at room temperature. The membranes were then 
incubated overnight with primary antibodies at 4°C, washed for 40 minutes 
with PBS 0,2% tween and incubated for 1 hour with a horseradish peroxidase -
conjugated secondary antibodies. Finally, protein bands were detected by an 
enhanced chemiluminescence system (ECL, Amersham Bioscience). 
Computer-acquired images were quantified using ImageQuant software 
(Amersham Bio-sciences).  
Immunoprecipitation was performed according to previous reports.(Illario 
et al., 2005). Briefly the cells were lysed in immunoprecipitation buffer (50 
mM Tris-HCl, pH 8.0, 5 mM EDTA, 150 mM NaCl, 1% Nonidet P-40, 0.5% 
sodium deoxycolate, 0.1% SDS, 10 mM NaF, 5 mM EGTA, 10 mM sodium 
pyrophosphate, and 1 mM phenylmethylsulfonylfluoride).  
Primary antibodies vs protein of interest and  Protein G plus/protein A agarose 
beads (Oncogene Science, Boston, MA) were used to immunoprecipitate 
corresponding proteins from 250 μg of total lysate. Non immune rabbit or 
mouse IgG were used as control. Mouse monoclonal antibodies to p44/p42 
MAPK, phospho-p44/p42 MAPK ,  Raf1 and CaMKII were from Santa Cruz 
Biotechnology. Polyclonal anti-phospho-CaMKII antibody (pT286-CaMKII) 
was from Promega (Madison, WI). Anti-IRS-1 and phospho-Ser612-IRS1, 
Anti- AKT and phospho AKT mouse monoclonal antibodies were from Cell 
Signaling Technology, Danvers, MA. 
 
3.4 CaMKII activity and inhibitors 
  
To inhibit CaMKII activity two different inhibitors have been used: KN93 and 
AntCaNtide. 
KN93 is a potent, selective and cell permeant pharmacological inhibitor of the 
CaMKs (IC50=370 nM). This drug is an isoquinolonesulfonamides and 
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functions as a competitive ATP antagonist (Tokumitsu et al., 1990). It was 
purchased from BIOMOL international. The CaMKII specific peptidic 
inhibitor Ant-CaNtide is derived from the endogenous CaMKII inhibitor 
protein CaMKIIN (Chang et al., 1998) and was made cell permeable by N-
terminal addition of an antennapedia-derived sequence (Ant-CaNtide: 
RQIKIWFQNRRMKWKKR PPKLG QIGRSKRVVIEDDRIDDVLK ). The 
reversed ant-CaNtide (Rev-antcantide) peptide was also used as a control.  
The inhibitory activity of AntCantide and Rev-AntCaNtide was tested on 
active full-length recombinant CaMKII (Signal Chem). In a first reaction step 
CaMKII was incubated for 30 minutes at 30 °C  with 5 mM CaCl2 and 5μM 
CaM in 50 µl of reaction mixture consisting of 50 mM HEPES pH 7.5, 10 mM 
MgCl2, 0,5 mM dithiothreitol (DTT), 2µM CaM, 100 nM microcystin, 0,5mM 
cold ATP .A 10 μl aliquot from the first reaction was than incubated with 
25mM EGTA, 0,5 mM Autocamtide (Hanson et al., 1989) and 50 µM ATP 
(1500 cpm/pmol [γ-32P]ATP) in order to determine CaMKII autonomous 
activity on its peptide substrate Autocamtide. The reaction was carried out for 
30 minutes at 30 °C and 20 µl aliquots of the reaction mixture were spotted 
onto p81 phosphocellulose filters (Upstate Biothechnology, Lake placid, NY) 
The level of [32P] incorporation into Autocamtide was determined by liquid 
scintillation counting. Purified CaM and Autocamtide were a kind gift from Dr. 
AR. Means, (Duke University, Durham, NC).  
 
3.5 Adenoviral Infection of Cells  
 
The catalytically inactive form of  CaMKIIα, K42M, was subcloned into 
pSP72(Promega). 
CaMKII  Kinase deficient mutant (CaMKII DN) adenoviruses were 
generated using the AdEasy system first described by He and colleagues and 
now available from Qbiogene (Draznin et al., 1987a).The methods used to 
generate these viruses were based on the initial description of the system, and 
the protocols published by Qbiogene (formerly, Quantum Biotechnologies).  
For fibroblasts infections: Approximately 1,5 X 106 cells were plated in 
100 mm dish 24 hours before infection, by which time they reached 70-80% 
confluency. The cells were incubated at 37°C with 1 ml of cell medium 
containing an amount of adenovirus of 100 viral particle/cell (vp/cell). After 30 
min of incubation,  6 ml of DMEM supplemented with 10% FBS were added 
to the plates. The experiments were performed 24 after the infection. 
CaMKII DN adenovirus and the mock control virus were a generous gift 
provided by A.R. Means (Duke University, Durham , NC) 
 
3.6 [3H]thymidine incorporation 
 
To determine DNA synthesis, cells were plated in 24-well plate, and 
serum-starved for 24 hours in DMEM, 0.5% BSA. Then, 0.5 μCi 
[3H]thymidine and 100nM insulin were added to the plates. After 24 h, the 
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plates were gently washed with PBS, then with 10% trichloroacetic acid 
(TCA), and incubated 10 min with 20% TCA at 4°C. TCA was removed and 
cells were lysed with 0.2% SDS for 15 min at 4 C. The lysates were then 
resuspended in 5 ml scintillation fluid and counted in a β-counter (Beckton 
Dickinson) 
 
3.7 Measurement of 2-deoxy-D-glucose uptake 
 
Confluent cells were incubated in DMEM supplemented with  0.25% 
albumin for 18 h at 37°C. The medium was removed and the cells were further 
incubated for 30 min in glucose-free HEPES buffer (5 mmol/l KCl, 120 mmol/l 
NaCl, 1.2 mmol/l MgSO4, 10 mmol/l NaHCO3, 1.2 mmol/l KHPO4, and 20 
mmol/l HEPES, pH 7.8, 2% albumin). The cells were incubated with 100 
nmol/l insulin for convenient time, supplemented during the final 10 min with 
0.2 mmol/l [14C]2-D-glucose. Cells were then solubilized and the 2-D-glucose 
uptake was quantified by liquid scintillation counting. 
 
3.8 Subcellular fractionation and western blot analysis of GLUT-4 
 
Serum starved L6 cells were exposed to 5μM AntCaNtide for 30 minutes 
and subsequently stimulated with insulin (100nM) for the indicated time. Cells 
were washed three times in ice cold PBS, pH 7.4 and homogenized in 500μM 
fractionation buffer [20 mM Tris-HCl, pH 7.4, 2 mM EDTA, 20 mM β-
mercaptoethanol, 1mM phenylmethylsulfonyl fluoride (PMSF), 10 μg/ml 
aprotinin, 10 μg/ml leupeptin ] by passing them 10 times through a 22-gauge 
needle. Broken cells were centrifuged at 1500 rpm for 15 min at 4°C to pellet 
nuclei. Supernatants were further centrifuged at 60000 rpm for 1 hour at 4°C to 
pellet plasma membranes. The last supernatant represented the cytosolic 
fraction. Plasma membranes (PM) were further purified by resuspending heavy 
membrane pellets in 500 ml fractionation buffer with 0,1% (v/v) Triton X-100. 
After centrifugation at 45000 rpm for 1 hour at 4°C, membranes were 
recovered from the upper phase. Based on Western blotting, the cell surface 
marker IR beta (beta subunit of insulin receptor) selectively localized to the 
plasma membrane fraction. 
 
3.9 Statistical analysis 
 
Results are presented as the mean ± SD. Statistical analysis was performed 
by using the t test. The level of significance was set at p less than 0.05. 
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4. RESULTS AND DISCUSSION 
 
4.1 Insulin induces Erk1/2 phosphorylation in L6 cells and human 
fibroblasts 
 
L6 cells and human fibroblasts in primary culture were serum starved for 24 hours 
and then stimulated with insulin at different concentrations (1-100 nM). The cells were 
then lysed in RIPA buffer, the proteins were resolved by SDS PAGE, and Erk1/2 
phosphorylation was evaluated by Western Blot with a phospho-specific antibody (p-
Erk1/2) (Fig 4.1). Although the starvation was maximal, and a longer starvation would 
result in loss of cell viability, Erk resulted phosphorylated to some extent in L6 cells at 
resting conditions, thus suggesting that serum starvation was incomplete, or that factors 
other than serum (i.e integrins engagement, autocrine factors) were responsible for the 
low-activation state of ERK 1/2 in these cells. Insulin stimulation induced a dose 
dependent increase of ERK 1/2 phosphorylation ,with a maximal effect at 100nM 
concentration in both L6 cells and fibroblasts (fig 4.1 A). In a primary culture of human 
fibroblasts Erk1/2 was barely phosphorylated at basal condition, and Insulin stimulated 
its phosphorylation in a dose dependent manner with a maximal effect at 100nM 
concentration. As in both cell types Insulin exerts its maximal effect at the 
concentration of 100nM, insulin was used at this concentration in the following 
experiments. 
In order to study the kinetics of insulin action on Erk phosphorylation, a time 
course was performed (Fig 4.1 B). L6 cells and fibroblasts were treated with insulin at 
different time points. In L6 cells strong Erk phosphorylation was visible after 5 minutes 
of insulin treatment, and it lasted up to 120 minutes, peaking at 30 minutes. In human 
fibroblasts insulin induction of Erk phosphorylation started after 5 min, the effect was 
maximal at 15 minutes and it declined after 60 minutes.  
Although these data are not original, they were necessary to characterize the cell models 
employed in this study. L6 cells have been extensively studied, and some difference in 
the kinetic of the insulin response have been observed between different L6 clones used 
in different laboratories. These data ensured that the L6 cells available in my laboratory 
are fully responsive to insulin. 
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Figure 4.1. Insulin induces Erk1/2 phosphorylation in L6 cells and human fibroblasts 
 
 L6 rat muscle cells and human fibroblasts in primary culture were serum starved overnight. The cells 
were stimulated with different concentration of  insulin (1,10,100 nM) (A). In a separate set of 
experiments L6 cells and human fibroblasts were treated with 100nM insulin for different times (B). 
The cells were lysed in RIPA and proteins, in equal amount, were resolved by SDS-PAGE. 
In either A and B cell lysates were analyzed by Western blot with total or phospho-specific (p-) 
antibodies to Erk-1/2.  
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4.2 Insulin stimulation induces intracellular increase of  Ca2+ 
concentration 
 
In order to evaluate whether insulin was able to initiate the cascade leading 
to CaMKII activation, I measured intracellular calcium concentration ([Ca2+]i)in 
the cells following insulin stimulation. To this purpose two different technical 
approaches were used: measurement of total [Ca2+]i increase by fluorimetric 
analysis and single cell analysis by confocal microscopy (Fig. 4.2). L6 cells 
were serum-starved overnight, and were subsequently loaded with Fura-2, 
detached from the plates  by trypsin and examined in suspension by 
fluorometry. [Ca2+]i remained unchanged for 15 minutes in un-stimulated cells. 
Subsequently, insulin was added at different concentrations and a [Ca2+]i 
increase appeared soon after stimulation. The [Ca2+]i increase was rather slow 
relative to other Ca2+ mobilizing agents and was dose-dependent upon the 
concentration of insulin used,  reaching about 5-fold increase by 10 min with 
100 nM insulin (Fig. 4.2 A). Although this result clearly demonstrated that 
insulin modulates [Ca2+]i in L6 cells, the analysis of skeletal cells in suspension 
is  far less physiologic  than in adherence condition and the kinetic of the 
response may be altered. For this reason [Ca2+]i was then determined at single 
cell level by confocal microscopy of adherent cells. After overnight starvation, 
L6 cells were loaded with Oregon Green and stimulated with  100 nM insulin. 
Again, insulin induced a slow increase of [Ca2+]i, thus confirming what was 
observed in the same cells in suspension with FURA-2. (Fig. 4.2 B, C). 
 
The role of Ca2+ in insulin signaling has been investigated in different 
studies with different approaches. Whereas some studies suggest that Ca2+ is 
involved in insulin signaling in several cell types (Draznin et al., 1987a; 
Pershadsingh et al., 1987b; Youn et al., 1994), others failed to demonstrate that 
insulin modifies [Ca2+]i (Cheung et al., 1987; Kelly et al., 1989; Klip and 
Ramlal, 1987). A recent study employing Indo-1 in single mouse muscle fibers 
suggested that insulin induce an increase of near-membrane Ca2+ 
concentration, while global myoplasmic [Ca2+]i does not significantly change 
(Bruton et al., 1999). In another study, insulin induced a very fast (2 sec) and 
transient [Ca2+]i increase in rat myotubes (Espinosa et al., 2004). My results 
show that insulin induces a slow and global [Ca2+]i in L6 cells. The apparent 
discrepancy between these results might be explained by differences in calcium 
homeostasis between the cell models employed and more importantly by the 
timing of the observation. Indeed, all the mentioned studies  investigated only 
the very early insulin effects and focus their attention to the first 30 min; on the 
contrary my study examined later effects of insulin, as my interest is focused 
on subsequent Ca2+-dependent enzyme activation. In my experiments, a very 
fast global effect in [Ca2+]i was not detectable, however a progressive increase 
of [Ca2+]i was evident after few minutes of insulin stimulation, and became 
 29
maximal by ~25 min. The increase of [Ca2+]i (global or restricted at CaMKII 
location) induced by insulin was of a magnitude sufficient to activate a 
signaling pathway involving CaMKII (see later results), whose activation is 
dependent upon Ca2+ . CaMKII activation by insulin was observed in rat soleus 
muscle but it was not demonstrated in 3T3-L1 adipocytes,  suggesting that the 
insulin dependent CaMKII activation might be tissue-specific 
(Konstantopoulos et al., 2007; Wright et al., 2004). 
I then investigated the effect of insulin on [Ca2+]i in adherent fibroblasts 
by confocal microscopy (data not shown). According to the literature, insulin 
induced a sharp and transient  [Ca2+]i increase. Again, as in L6 cells, this 
[Ca2+]i , although modest and transient, it was sufficient to induce CaMKII 
activation (see later results). 
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 Figure 4.2  Insulin induces [Ca2+]i increase 
 
A) L6 cells were serum starved and loaded with Fura-2.The cells were 
then trypsinized and [Ca2+]i was measured by a fluorimeter for 15 min 
before insulin stimulation (arrow) and for the following 15 min. Insulin 
concentrations were: 1 nM, empty circle, dotted line; 10 nM empty 
circles continuous line; 100 nM full circles. B)and C), L6 cells grown 
onto glass coverslips were loaded with Oregon green, stimulated with 
100nM insulin and observed by confocal microscopy as described in 
Materials and Methods. [Ca2+]i is reported Relative fluorescence = 
(fluorescence – fluorescence at 0 point)/ fluorescence at 0 point) 
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4.3 Insulin induces CaMKII phosphorylation in L6 cells and in human 
fibroblasts 
 
To evaluate whether insulin stimulated [Ca2+]i increase was followed by 
CaMKII activation, I evaluated CaMKII activity in L6 cells and fibroblasts by 
Western Blot with a phospho-specific antibody versus the phosphorylated 
Thr286 of the regulatory domain of CaMKII. The phosphorylation of this 
residue is an index of CaMKII autonomous activity  
L6 cells and fibroblasts were exposed to 100nM insulin for the indicated 
time (Fig. 4.3). In L6 cells insulin treatment induced CaMKII phosphorylation 
on Ser 286 as early as 5 min and it lasted up to 120 min (Fig. 4.3 A).  A similar 
effect was observed in fibroblasts, where CaMKII phosphorylation was visible 
from 5 to 60 min. (Fig 4.3 B). Although a basal minimal activation of CaMKII 
was present, Insulin was able to induce a fast and long lasting increase of 
Thr286 phosphorylation, demonstrating that also the very modest and transient 
[Ca2+]i increase observed in fibroblasts was a sufficient activating signal. The 
long-lasting activation of CaMKII in both cell types is not surprising, because 
this kinase has unique activation features that enable it to be active after the 
Ca2+ concentration is dropped off. Indeed the binding of Ca2+/CaM to CaMKII 
is necessary only to initiate the autophosphorylation process of the multimeric 
kinase, but not for its autonomous activity. 
These data show that CaMKII is activated upon insulin stimulation in two 
different cell types and suggest that it can be considered as a new component of 
insulin signalling. 
 
 
 
 
 
 
 
 
Figure 4.3 Insulin induces CaMKII phosphorylation in L6 cells and in 
human fibroblasts 
 
L6 cells (A) and human fibroblasts (B) were serum starved over night and 
stimulated with 100nM insulin at the indicated times. Cell lysates were analyzed 
by Western blot with antibodies to total CaMKII or to phosphorylated T286-
CaMKII (p-CaMKII).  
 32
4.4 Inhibition of CaMKII activity abrogates insulin stimulated Erk-1/2 
phosphorylation in L6 cells and in fibroblasts. 
 
A cross-talk between the Ca2+/CaMKII and Erk-1/2 pathway was 
previously demonstrated in integrin signalling (Illario et al., 2005). In order to 
investigate the possible existence of a similar cross-talk in insulin signalling, I 
tested the effects of two CaMKII inhibitors (KN93 and AntCaNtide) on Erk-1/2 
phosphorylation in response to insulin. KN93 is a well known CaMKs 
pharmacological inhibitor, that function as an ATP antagonist, while 
AntCaNtide is a CaMKII specific inhibitory peptide (Chang et al., 1998). In the 
inset  AntCaNtide efficiency was tested in vitro on recombinant active CaMKII. 
Reversed AntCaNtide (R-antcantide) was used as a negative control. In a first 
reaction step, active full-length recombinant CaMKII was incubated with CaCl2, 
CaM and cold ATP. In a second reaction step an aliquot from the first reaction 
was incubated with CaMKII peptidic substrate Autocamtide, EGTA and 
[γ32P]ATP. The reaction mixture was spotted onto p81 phosphocellulose filters 
and the level of [32P] incorporation into Autocamtide was determined by liquid 
scintillation counting. 
AntCaNtide completely abolished CaMKII activity on its substrate 
Autocamtide, while R-antcandite had no effect on CaMKII activity, 
demonstrating the efficiency of AntCaNtide. The specificity of AntCaNtide 
versus different kinases was previously tested. This peptide demonstrated to 
have no inhibitory activity on CaMKI, CaMKIV, Raf1, Mek and Erk (Illario et 
al., 2003). 
 In order to investigate the crosstalk between Ras/Erk and Ca2+/CaMKII 
pathways, L6 cells were stimulated with insulin in the presence of KN93 at the 
indicated μM concentration, or 5 μM AntCaNtide, and the levels of Erk-1/2 
phosphorylation were evaluated by western blot (Fig. 4.1 A). KN93 treatment 
reduced Insulin-induced Erk phosphorylation in a dose dependent manner, with 
a maximal effect at 10 μM concentration. Treatment with 5 μM AntCaNtide 
completely abolished Erk-1/2 phosphorylation induced by 30 minutes of insulin 
stimulation as well as its basal phosphorylation. 
These data suggest that in a rat muscle cells model, Erk-1/2 activation 
requires active CaMKII. To validate the general role of CaMKII in the insulin 
stimulated Erk-1/2 signalling, similar experiments were replicated in primary 
culture of human fibroblasts. Fibroblasts from normal subjects were cultured in 
serum-free medium for 24 h. Erk1/2 phosphorylation was determined by 
western blot upon stimulation with insulin alone, or in the presence of CaMKII 
inhibitors KN93 or antCaNtide (Fig. 4.1 B). Likewise in L6 cell line, in these 
cells Erk-1/2 phosphorylation induced by insulin was abrogated by CaMKII 
inhibitors. In a separate set of experiments, CaMKII inhibition in stimulated 
fibroblasts was achieved by infection with a defective-recombinant adenovirus 
expressing a dominant-negative CaMKII mutated form (CaMKII-DN). Erk-1/2 
phosphorylation was stimulated by insulin in fibroblasts infected with a mock 
adenovirus.  In the cells infected with the CaMKIIDN-expressing adenovirus, 
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insulin was not able to induce ERK1/2 phosphorylation. (Fig. 4.4 C). In 
conclusion, these results strongly suggest that insulin-induced Erk activation is 
CaMKII dependent both in L6 cell and in primary culture of human fibroblasts, 
indicating that this is a general mechanism of Insulin action, and is not 
restricted to a particular tissue. 
The role of CaMKII in the modulation of ERK phosphorylation was 
previously demonstrated also in a thyroid cell model following cell adhesion to 
the extracellular matrix. (Illario et al. 2005). Altogether, these observations 
support the hypothesis that CaMKII plays a pivotal role in the activation of 
ERK pathway in response to different stimuli and in different cell types. 
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Inset . CaMKII activity on Autocamtide in vitro.
 
 Active recombinant CaMKII was incubated with its peptidic 
substrate Autocamtide, in the presence of AntCaNtide or R- 
AntCaNtide and [γ-32P]ATP. The reaction was performed as 
described in materials and methods. The results are presented as 
total incorporated cpm. Data are reported as the mean +/- standard 
deviation from duplicate experimental point. 
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Figure 4.4 Inhibition of CaMKII abrogates insulin stimulated Erk-1/2 
phosphorylation in L6 cells and in fibroblasts. 
 
L6 cells (A) and human fibroblasts (B) were treated with KN93 at indicated μM 
concentrations, or with 5 μM ant-CaNtide, or with 5 μM R-ant-CaNtide and then 
stimulated with 100nM insulin (ins). The amount of total ERK1/2 (ERK1/2) and 
phosphorylated ERK1/2 (p-ERK1/2)   was determined by western blot . Human 
fibroblasts were infected with a dominant negative recombinant adenovirus (CaMKIIDN) 
or a mock adenovirus as a control. The cells were serum starved overnight  and 
stimulated with insulin. The level of ERK1/2 phosphorylation was evaluated with 
western blot (C). 
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4.5 Insulin stimulates CaMKII association with Raf1 
 
In a thyroid cell model, FN-induced Raf1 activation was dependent upon 
CaMKII activity (Illario et al., 2003; Illario et al., 2005b). In order to 
investigate whether the crosstalk between CaMKII and Ras/Erk pathway in 
insulin signalling occurred on Raf1, a co-immunoprecitation assay was 
performed in L6 cells. Serum starved cells were treated, when indicated,  with 
10 μM KN93 or 5 μM AntCaNtide, and then stimulated with 100 nM Insulin. 
CaMKII was immunoprecipitated from cell extracts and the Co-
immunoprecipitated Raf1 was visualized by western blot. Insulin induced 
CaMKII binding to Raf1, while KN93 and AntCaNtide treatment disrupted the 
CaMKII/Raf1 complex, thus indicating that the interaction was dependent upon 
CaMKII activity (fig 4.5). These data suggest that  the interplay between 
CaMKII and Ras/Erk pathway occurs at Raf1 level also in Insulin signalling. 
The interaction between CaMKII and Raf1 is a relevant point not yet fully 
investigated. A molecular approach to investigate this mechanism is on going 
in the laboratory where I worked for this thesis. Raf1 is a complex kinase 
requiring phosphorylation at multiple sites to be fully activated. In vitro 
phosphorylation of Raf1 by CaMKII has been demonstrated, although the site/s 
have not been identified so far. One hypothesis is that Raf1 is phosphorylated 
by CaMKII in one or more sites necessary for its activation by other kinases 
(i.e Src) 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5  Insulin stimulates CaMKII association with Raf1
 
L6 cells were serum starved and stimulated with 100nM insulin for 30 min in the presence of 10μM 
KN93 or 5μM antCaNtide. Endogenous CaMKII was immuno-precipitated (IP) from cell extracts by a 
specific antibody and protein G plus/protein A agarose beads. An unrelated monoclonal antibody 
was used as a negative control (ctrl-IgG). 
After protein separation by SDS-PAGE, immuno-precipitated CaMKII and coprecipitated Raf1 were 
detected by western blot. (WB) 
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4.6 Inhibition of CaMKII abrogates insulin-induced thymidine 
incorporation in L6 cells and human fibroblasts. 
 
In order to study the role of CaMKII in stimulation of cell proliferation 
following Erk activation, a [3H] thymidine incorporation assay was performed. 
[3H] thymidine incorporation was used to measure DNA synthesis in L6 
cells and fibroblasts cultured in serum-free medium and then stimulated with 
100 nM insulin for 24 h. Insulin stimulation induced a 65% increase of 
[3H]thymidine incorporation in L6 cells. Both KN93 and AntCaNtide 
completely abolished such a stimulation demonstrating that, according with the 
results on inhibition of Erk phosphorylation, insulin-induced DNA synthesis 
requires CaMKII activity. Human fibroblasts displayed a similar behaviour. In 
this model  CaMKII inhibition was achieved by KN93 or AntCaNtide, and by 
infecting the cells with the CaMKIIDN recombinant adenovirus. [3H]thymidine 
incorporation increased 85% following insulin stimulation, and it was reduced 
by either treatment with CaMKII inhibitors or CaMKIIDN adenovirus 
infection (fig 4.6). 
These data underline the importance of CaMKII in the regulation of 
Insulin mitogenic effects in different cell types. 
 
 
 
Figure 4.6 Inhibition of CaMKII abrogates insulin-induced thymidine incorporation in L6 
cells and human fibroblasts. 
 
L6 cells were plated in 24-well plates, and serum-starved for 24 hours. In a separate experiment 
fibroblasts were infected with a CaMKII dominant negative recombinant adenovirus (CaMKIIDN) 
or a mock adenovirus, and serum starved for 24 hours. 
Both L6 and fibroblasts were treated, when indicated,  with KN93 or antCaNtide for 30 min and 
then [3H] thymidine and 100 nM insulin were added to the plates. Data are reported as mean ± 
SD of quadruplicate experiments. *, significant vs. CTRL point. **, significant vs. insulin alone. 
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4.7 CaMKII inhibition abrogates insulin induced Ser612-IRS1 
phosphorylation and enhances the binding of p85 to IRS1 
 
In L6 myotubes both IRS-1 and IRS-2 are responsible for insulin-induced 
Erk-1/2 activation, but only IRS-1 activates Akt1 and is responsible for GLUT-
4 translocation to the plasma membrane, and consequent glucose uptake 
(Huang et al., 2005). Some studies demonstrate that Erk1/2 is involved in a 
negative feedback by which, after the initial stimulation of PI3K/Akt/GLUT-4 
cascade induced by insulin, this is downregulated (Bard-Chapeau et al., 2005; 
De Fea and Roth, 1997). Once activated by insulin, Erk phosphorylates IRS1 at 
Ser612. This residue is located close to Tyr608, the major PI3K binding site 
(Mothe and Van Obberghen, 1996). The consequence of this phosphorylation 
is the inhibition of the binding of the regulatory p85 subunit of PI3K to IRS1, 
and the consequent inhibition of the downstream signal that leads to Akt 
activation. 
In the liver, the major site for glucose production and storage, this mechanism 
regulates glucose metabolism and finally influences  glycemia (Saltiel and 
Kahn, 2001). Experimental evidences in liver knockout Grb2 associated binder 
1 (Gab1) mice, demonstrated that mitogenic and metabolic effects of Insulin 
can be dissociated by interfering with one component of the Erk-1/2 kinase 
cascade.  
 As CaMKII is involved in Erk activation following insulin stimulation, I 
investigated a possible role for CaMKII in the control of  insulin-induced 
pathways that lead to its major metabolic effect: glucose uptake in its target 
tissues, like skeletal muscle. 
While Fibroblasts do not express GLUT-4 and glucose uptake is not an 
insulin dependent phenomenon, L6 skeletal muscle cells are responsive to 
insulin-induced signals leading to GLUT-4 translocation to the plasma 
membrane and to the increase of glucose uptake. For this reason, L6 cells were 
chosen as a model to study the role of CaMKII in the metabolic signalling of 
Insulin. 
L6  cells were pre-treated with 5 μM AntCaNtide (ant) or 10 μM KN93 
(Kn) for 30 min and then stimulated with 100 nM insulin for the indicated time 
(Fig. 4.6). Cell extracts were analyzed by Western blot with antibodies versus 
phosphorylated-Ser612-IRS-1 (pS612) or total IRS-1. Insulin stimulation 
induced a strong phosphorylation of IRS1 at Ser 612 from 30 to 120 min. 
CaMKII inhibition by AntCaNtide completely abrogated insulin induced IRS1 
phosphorylation at Ser612 for the entire time-course (Fig. 4.6 A). 
This data show that CaMKII is important for Erk induced phosphorylation 
of IRS1-Ser612, and therefore suggest its involvement in the negative feedback 
loop that leads to the downregulation of the PI3K pathway. 
The next step was to evaluate whether CaMKII activation could affect the 
insulin-induced-binding of p85 to  IRS1. 
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IRS-1 was immunoprecipitated from cell extracts. The co-precipitated p85 
subunit of PI3K was detected by a specific antibody. (Fig 4.6 B) 
The association between  p85 and IRS1 was induced by insulin after 30 
min, and it decreased at 120 minutes.  The binding of these two proteins was 
increased after treatment with AntCaNtide at 120 min. These data sustain the 
hypothesis that CaMKII is involved in the regulation of the negative feedback 
that leads to the downregulation  of PI3K/Akt signal. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7 CaMKII inhibition abrogates insulin induced Ser612-IRS1 phosphorylation and 
enhances the binding of p85 to IRS1 
 
L6 cells were pre-treated, when indicated, with 5 μM antCaNtide (ant) or 10 μM KN93 (Kn) for 30 
min and stimulated with 100 nM insulin for the indicated time. 
A)Cell extracts were analyzed by Western blot with antibodies vs phosphorylated-Ser612-IRS-1 
(pS612) or total IRS-1. B) IRS-1 was immunoprecipitated from cell extracts. The co-precipitated 
p85 subunit of PI3K was detected by a specific antibody.  
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4.8 Insulin-induced Akt phosphorylation is upregulated by CaMKII 
inhibition. 
  
One of the earliest events that follows Insulin-induced PI3K activation is 
Akt phosphorylation. As CaMKII  is involved in the control of PI3K binding to 
IRS1 induced by Insulin, I evaluated the effects of CaMKII inhibitor 
antCaNtide on Akt phosphorylation at Ser 473. The timing of this phenomenon 
is important to understand the complicated interplay between the different 
signalling pathways induced by Insulin, therefore a time course was performed.  
L6 cells were pre-treated with 5μM AntCaNtide and then stimulated with 
Insulin 100nM for the indicated times. Akt phosphorylation was evaluated by 
western blot with a phospho-specific-antibody. Insulin induced Akt 
phosphorylation was maximal at 30 minutes, it decreased at 60 minutes and it 
was completely abolished after 120 minutes. The treatment with antCaNtide 
resulted in the increase of  Akt phosphorylation at 30 and 60 minutes and it 
restores Akt phosphorylation at 120 minutes. (fig.4.8) 
According to this result, CaMKII  participate to the late downregulation of 
Akt phosphorylation following stimulation by insulin.  
 
 
 
 
  
 
 
 
 
 
 
 
Figure 4.8 Insulin-induced Akt phosphorylation is up regulated by CaMKII inhibition. 
 
Serum starved L6 cells were pre-treated with 5 μM antCaNtide and stimulated with 100nM Insulin 
for the indicated time. The cell lysates were analyzed by Western blot with total or phospho-specific 
(p-) antibodies to AKT. 
 
 
 40
 4.9 CaMKII inhibition abrogates the downregulation  of insulin-induced 
GLUT-4 translocation to the plasma membrane. 
 
One of the mechanisms by which Insulin controls glucose homeostasis is 
glucose uptake in muscle and fat cells, mediated by the insulin-regulated  
glucose transporter GLUT-4. In resting conditions, GLUT-4 is sequestered 
inside the cytoplasm of muscle and fat cells. Insulin induces the redistribution 
of GLUT-4 from intracellular storage sites to the plasma membrane by 
activating PI3K/Akt pathway. 
According to my data, CaMKII inhibition enhances insulin induced Akt 
signal, therefore I investigated  whether CaMKII inhibition could affect  insulin 
induced GLUT-4 translocation. L6 cells were pre-treated with CaMKII 
inhibitor AntCaNtide (ant) for 30 min and then stimulated with 100nM insulin 
at the indicated times. Plasma membrane (PM) and intracellular membrane 
from lysed cells were fractionated by centrifugation. Equal amounts of plasma 
membrane and intracellular membrane proteins were separated  by SDS PAGE 
and immunoblotted with GLUT-4 antibody. In figure 4.9, GLUT-4 levels in 
plasma membrane are shown (PM) .GLUT-4 levels in the intracellular 
membrane didn’t change ( not shown). 
 The amount of GLUT-4 translocated to the PM upon Insulin stimulation was 
maximal at 30 min and decreased after 120 min. The reduction of GLUT-4 
translocation after 120 min was prevented by CaMKII inhibition achieved by 
AntCaNtide treatment. Therefore, CaMKII might represent a novel regulatory 
element in the control of glucose homeostasis through the regulation of GLUT-
4 transporter 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9 CaMKII inhibition abrogates the downregulation  of insulin-
induced GLUT-4 translocation to the plasma membrane. 
L6 cells were incubated in the absence or the presence of AntCaNtide (ant) for 30 
min and subsequently treated with 100nM insulin at the indicated times. 
The cells were homogenized and subjected to subcellular fractionation to generate 
fractions enriched in plasma membrane (PM) and intracellular membranes (not 
shown). Equal amounts of plasma membrane and intracellular membrane proteins 
were separated  by SDS PAGE and the amount of GLUT-4 in the PM was 
visualized by Western Blot.  
The beta subunit of insulin receptor ( IR beta) was used as a cell surface marker. 
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4.10 CaMKII inhibition abrogates the downregulation  of insulin-induced 
Glucose uptake in L6 cells 
 
According to the previous experiments, CaMKII is involved in the 
regulation of the pathways leading to GLUT-4 translocation to the cell surface, 
therefore I evaluated the effects of CaMKII inhibitor KN93 and AntCaNtide on 
one of the most important insulin metabolic effect: glucose uptake by muscle 
cells. 
L6 cells were pre-treated with KN93 or AntCaNtide for 30 min, and then 
stimulated with 100nM insulin at the indicated times. [14C] 2-D glucose was 
added to the medium in the last 10 min of Insulin treatment, and 2-D-glucose 
uptake was determined (Fig. 4.10). Glucose uptake was stimulated by Insulin 
by 30 min, and it returned to the basal level within 120 min. KN93 treatment 
increased basal glucose uptake and, consistent with the previous results, it 
inhibited the downregulation of glucose uptake at 120 min. A similar result 
was obtained with AntCaNtide (data not shown). These data demonstrate that 
CaMKII has a pivotal role in insulin metabolic effects, participating to the 
downregulation of glucose uptake mediated by Erk activation.  
The involvement of Ca2+ in insulin-stimulated glucose transport has long 
been debated, and a large body of evidence associates [Ca2+]i variation with 
modulation of glucose transport. Ca2+ channel blockers such as nifedipine, or 
the calmodulin inhibitor W7, reduced insulin-stimulated glucose transport in 
skeletal muscle cells (Cartee et al., 1992; Youn et al., 1994; Young and Balon, 
1997). Recently, another study proposed in 3T3-L1 adipocytes a permissive 
role for CaMKII in the insulin-stimulated glucose transport through a 
mechanism not involving GLUT-4 translocation (Konstantopoulos et al., 
2007). However, other studies raised the possibility that Ca2+ might have 
biphasic effects on insulin-stimulated glucose transport, depending on the 
magnitude of [Ca2+]i variations: large increases in [Ca2+]i induced by exposure 
to ionomicin or depolarization inhibits insulin stimulated glucose transport, 
whereas small rises in [Ca2+]i are stimulatory.(Draznin et al., 1987b)  
The disaccording results obtained to date are probably the consequences of 
Ca2+/CaMKII effects exerted at multiple sites and at different times. My results 
are not in conflict with the positive role of CaMKII proposed in some studies. 
All these studies investigated the role of Ca2+ signaling within 30 min of 
insulin stimulation, whereas I focused my attention on the downstream 
negative feedback loop involving the Erk/IRS-1 interplay. Thus, in the model I 
propose, Ca2+/CaMKII signaling pathway mediates both the early insulin-
stimulated glucose uptake as well as its following downregulation. 
In this model, CaMKII is an important regulator of insulin pathway. The 
role of CaMKII might spam in both metabolic and mitogenic effects of insulin 
on human diseases, such as hypertension and diabetes, both characterized by 
insulin resistance.  
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Figure 4.10 CaMKII inhibition abrogates the downregulation  of insulin-induced 
Glucose uptake in L6 cells 
 
L6 cells were treated with 10 μM KN93  and then stimulated with 100nM insulin  at the 
indicated times. [14C]2-D glucose was added to the medium in the last 10 min of Insulin 
treatment and 2-D-glucose uptake was determined by liquid scintillation counting. Data are 
reported as mean ± SD of 3 independent experiments in triplicates. *, significant vs. insulin 
alone.  
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5. CONCLUSIONS 
I investigated the role of CaMKII in Insulin signaling cascade in a skeletal 
muscle cell line (L6) and in human fibroblasts. The results of the present thesis 
demonstrate that insulin receptor activates a Ca2+/CaMKII dependent pathway 
that integrates with insulin signaling network, and controls cell growth and 
glucose uptake. (Fig 5.1) 
CaMKII plays a pivotal role in the modulation of Erk activation in a 
number of models. A crosstalk between CaMKII and Erk pathway was first 
demonstrated in response to cell adhesion to extracellular matrix in a model of 
thyroid cells. Illario et al. demonstrated that CaMKII participates to Raf1 
activation and controls Erk phosphorylation following integrin stimulation by 
fibronectin. (Illario et al., 2003; Illario et al., 2005).  
To determine whether CaMKII/Erk pathway interplay was a general 
mechanism in the control of cell proliferation, I investigated the role of 
CaMKII in insulin signaling. 
In skeletal muscle cells, insulin initiates different signaling pathways. The 
PI3K/Akt cascade is responsible for GLUT-4 translocation to the plasma 
membrane and glucose transport, whereas Ras/Erk pathway regulates cell 
growth and proliferation. 
In the first part of my study I investigated the role of CaMKII in insulin 
mitogenic effects. I provide evidences that insulin promotes an increase of 
intracellular calcium concentration and CaMKII activation, in both L6 cells 
and fibroblasts. CaMKII inhibitors completely abolished Erk-1/2 
phosphorylation as well as [3H] thymidine incorporation induced by insulin 
stimulation. These observations extend the role of CaMKII and indicate that 
this mechanism is not restricted to integrins, but it is a general phenomenon 
that may be relevant for the biological effects of many growth factors and 
hormones. 
In some cell types, like skeletal muscle cells and adipocytes, after the 
initial stimulation of glucose uptake, insulin promotes its downregulation by 
activating a negative feedback. The molecular mechanism of this feedback 
consist in the phosphorylation of IRS1 at Ser-612 by Erk, that impairs PI3K 
binding to IRS1 and the consequent Akt activation, thus arresting the 
translocation of GLUT-4 to the plasma membrane and finally reducing glucose 
uptake. My study demonstrate that CaMKII, through Erk1/2, modulates this 
negative feedback. CaMKII inhibition, indeed, abrogates the downregulation of 
insulin induced glucose uptake. As several factors are able to modify [Ca2+]i, 
this might represent a site where different effectors converge to modulate 
insulin metabolic effects at single tissue level. 
 
In conclusion, my results can be summarized as follows: 
1. A Ca2+/CaMKII signal is activated following insulin stimulation 
2. CaMKII participates to insulin induced Erk activation and cell 
proliferation 
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3. CaMKII is involved in the control of Akt signalling by mediating 
Erk- induced phosphorylation of IRS1 at Ser 612 
4. CaMKII inhibition leads to a sustained GLUT-4 translocation to 
the plasma membrane and glucose uptake in response to insulin 
 
Therefore, CaMKII can be considered as a new target of insulin signaling, 
involved in the regulation of two important effects of insulin action such as cell 
proliferation and glucose homeostasis. This kinase, by modulating the insulin 
signal that leads to Erk1/2 activation, might have a role in the pathogenesis of 
insulin resistance. The contribution of CaMKII to these changes in insulin 
receptor function is worthy to be further investigated.  
The identification of a novel molecular mechanism involved in the 
modulation of insulin signaling and glucose metabolism provides new targets 
for pharmacological interference, and CaMKII might represent a novel 
therapeutic target, offering new insights to the treatment of hyperglycemia. 
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Figure 5.1 Schematic diagram of the insulin receptor signaling in L6 cells. 
  
Activation of the insulin receptor generates the IRS-1/2→PI3K→Akt signaling pathway and 
promotes glucose uptake. Insulin receptor activation generates two other signals: 
[Ca2+]i→CaMKII and IRS-1/2→Erk-1/2. They both participate to Raf-1 activation, leading to 
stimulation of cell proliferation. Activated Erk-1/2 phosphorylates S612-IRS-1 and inhibits its 
association with PI3K and in turn Akt activation, thus generating a negative feedback loop that 
down-regulates insulin stimulated glucose uptake. Abbreviations: IR, insulin receptor; IRS, 
insulin receptor substrate; Erk, extracellular regulated kinase; PI3K, phosphatydidlinositol 3-
kinase; Akt, protein kinase B; CaMKII, calcium-calmodulin dependent kinase II. 
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Werecentlydemonstrated inan immortalized thyroid cell line
that integrin stimulation by fibronectin (FN) simultaneously
activates two signaling pathways: Ras/Raf/MAPK kinase
(Mek)/Erk and calcium (Ca2)/calcium calmodulin-dependent
kinase II (CaMKII). Both signals are necessary to stimulate
ErkphosphorylationbecauseCaMKIImodulatesRas-induced
Raf-1 activity. In this study we present evidence that extends
these findings to normal human thyroid cells in primary cul-
ture, demonstrating its biological significance in amore phys-
iological cell model. In normal thyroid cells, immobilized FN-
induced activation of p21Ras and Erk phosphorylation. This
pathway was responsible for FN-induced cell proliferation.
Concurrent increase of intracellular Ca2 concentration and
CaMKII activation was observed. Both induction of p21Ras
activity and increase of intracellularCa2 concentrationwere
mediated by FN binding to v3 integrin. Inhibition of the
Ca2/CaMKII signal pathway by calmodulin or CaMKII inhib-
itors completely abolished the FN-induced Erk phosphoryla-
tion. Binding to FN induced Raf-1 and CaMKII to form a pro-
tein complex, indicating that intersection between Ras/Raf/
Mek/Erk and Ca2/CaMKII signaling pathways occurred at
Raf-1 level. Interruption of the Ca2/CaMKII signal pathway
arrested cell proliferation induced by FN. We also analyzed
thyroid tumor cell lines that displayed concomitant aberrant
integrin expression and signal transduction. These data con-
firm that integrin activation by FN in normal thyroid cells
generates Ras/Raf/Mek/Erk and Ca2/CaMKII signaling path-
ways and that both are necessary to stimulate cell prolifera-
tion, whereas in thyroid tumors integrin signaling is altered.
(J Clin Endocrinol Metab 90: 2865–2873, 2005)
THYROID FOLLICULAR CELLS are arranged in the thy-roid gland to form follicles, round-shaped structures
that represent the functional unit of the gland. A basal lamina
surrounds the follicles, and thyroid follicular cells, like any
other epithelial cell, are attached to the extracellular matrix
(ECM) proteins that constitute the basal lamina. Fibronectin
(FN) together with collagen and laminin represents one of
these ECM proteins (1, 2). We previously demonstrated that
FN together with other soluble factors (TSH, epidermal
growth factor, insulin, and IGF) controls essential biological
functions in the thyroid cell, including proliferation and sur-
vival (3–5). Control of cell proliferation and survival exerted
by ECM is of fundamental relevance for tissue homeostasis
and is important to neoplastic cells that must proliferate and
survive in ectopic environments or denied adhesion, while
metastasizing through the bloodstream (6). Cell adhesion to
ECM is mainly mediated by integrins, a large family of cell
surface receptors widely expressed in all tissues. Integrins
are heterodimeric receptors located at basal cell membrane
whose expression pattern is tissue type dependent (7–9).
Membrane distribution of some integrins is restricted to sub-
cellular structures known as focal adhesions, which contain
structural and signaling molecules including actin, focal ad-
hesion kinase (Fak), Srk, protein kinase C, and paxillin. In-
tegrin activation can generate multiple signals that regulate
cell behavior through the modulation of ion concentration
(Ca2, Na, H) or lipid metabolism. Although integrins do
not display direct kinase activity, their activation by binding
to ECM proteins generates signals that include kinase cas-
cades. In a thyroid cell line obtained by immortalizing hu-
man fetal thyroid cells (TAD-2), integrin clustering by bind-
ing to FN generates two signaling pathways: Fak/Ras/Raf-
1/MAPK kinase (Mek)/Erk that mediates FN-induced
proliferation, and the phosphatidylinositol-3 kinase (PI-3K)
pathway involved in cell survival (10).
We recently demonstrated in the same cell type that in-
tegrin binding to FN also generates a third pathway that is
calcium/calcium calmodulin-dependent kinase II (Ca2/
CaMKII). The latter modulates the Ras/Raf-1/Mek/Erk
pathway by binding to Raf-1 and regulating its activity (11).
Although TAD-2 cells and normal thyroid cells in primary
cultures display common integrin profile and FN-induced
First Published Online February 1, 2005
Abbreviations: BSA/PBS, 0.5% BSA and PBS; Ca2, calcium; [Ca2]i,
intracellular free calcium concentration; CaMKII, calcium calmodulin-
dependent kinase II; CDK, cyclin-dependent kinase; ECM, extracellular
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calf serum; FN, fibronectin; Mek, MAPK kinase; PI-3K, phosphatidyl-
inositol-3 kinase; PTC, papillary thyroid carcinoma; RFI, relative fluo-
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behavior (4, 12), a direct demonstration of the existence of
such integrin-generated signal in normal thyroid cells in
primary cultures is lacking. Moreover, because the pattern
expression of adhesion molecules changes after cell trans-
formation, it is important to determine which integrin re-
ceptor generates the signals that mediate FN-induced
proliferation.
Thus, we investigated the signal pathways generated by
FN-dependent integrin activation in normal human thyroid
cells in primary culture. We provide evidence that FN bind-
ing to the integrin v3 activates the Ras/Raf-1/Mek/Erk
and the Ca2/CaMKII pathways and that both are necessary
to promote FN-induced proliferation.
Materials and Methods
Cell cultures
Tissue specimens were obtained at surgery from contralateral lobes
of thyroid papillary carcinomas or internodular tissue of nodular goiters
of subjects undergoing thyroidectomy. Informed consent for cell culture
preparation was obtained from patients undergoing thyroidectomy.
Cell cultures were prepared as previously described (4). Briefly, tis-
sues were chopped by scalpels in small pieces and digested by type IV
collagenase (Sigma Chemical Co., St. Louis, MO) 1.25 mg/ml in Ham’s
F-12 medium (F-12) and 0.5% BSA overnight at 4 C under rotation. Cells
were pelleted by centrifugation at 150  g for 5 min, washed twice in
BSA-F-12, seeded in petri dishes, and cultured in 5% CO2 atmosphere
at 37 C in F-12 supplemented with 10% fetal calf serum (FCS). Medium
was changed every 3–4 d, and the cellswere harvested by treatmentwith
0.5 mm EDTA in calcium- and magnesium-free PBS containing 0.05%
trypsin. The follicular origin of the cultures was confirmed by flow
cytofluorometry searching for cytokeratin and thyroglobulin as previ-
ously described (12). More then 98% of the cells in culture were positive
for cytokeratin and thyroglobulin. For each experiment, single individ-
ual cultures were used and results pooled for statistical analysis.
The TAD-2 cell line, obtained by Simian virus 40 infection of human
fetal thyroid cells was generously donated by Dr. T. F. Davies (Mount
Sinai, New York, NY) (13). Thyroid papillary carcinoma cell lines NPA
and TPC-1 were kindly donated by M. Nagao (Tokyo, Japan) (14). All
cell lines were cultured in F-12 supplemented with 10% FCS.
Coated plates were prepared as follows: the plates were filled with
PBS, 1% heat-denatured BSA (Sigma, St. Louis, MO), or 100 g/ml
human FN (Collaborative Research, Bedford, MA). After overnight in-
cubation at 4 C, the plates were washed with PBS three times and used.
Antibodies and flow cytometric analysis
For intracellular immunofluorescence (cytokeratin and thyroglobu-
lin), cells were fixed in 3.5% paraformaldehyde, 0.2% Tween 20 in PBS,
washed twice in PBS, and resuspended in 0.5%BSA andPBS (BSA/PBS);
immunostainingwas then performed using fluorescein-conjugated anti-
cytokeratin antibodies (Ortho, Raritan, NJ) or rabbit antihuman thy-
roglobulin serum followed by sheep antirabbit IgG as a fluorescein-
conjugated secondary antibody. Serum from nonimmunized rabbits or
nonspecific fluoresceinated immunoglobulins of the same isotype was
used as controls. Cells were then analyzed by flow cytometry using a
FACScan apparatus (Becton Dickinson, Mountain View, CA). Mono-
clonal antibody of mouse origin against 1-subunit (clone A1A5) was
kindly donated by Dr. M. E. Hemler (Dana Farber Cancer Institute,
Boston, MA) and anti-3 (J143) by Dr. L. J. Old (Ludwig Institute for
Cancer Research, New York, NY). Monoclonal antibody to 5 was pur-
chased from Telios (San Diego, CA); anti-v3 and anti-v5 were
purchased fromChemicon (Temecula, CA); fluorescein-conjugated anti-
mouse and antirabbit IgG and horseradish peroxidase-conjugated anti-
rabbit IgG were purchased from Ortho. Flow cytometric analysis was
performed as follows: cells harvested from subconfluent cell cultures by
PBS containing 0.05% trypsin were incubated with the primary mono-
clonal antibody for 1 h at 4 C in BSA/PBS, washed in the same buffer,
and incubated again with the secondary fluorescein-conjugated anti-
body for 30 min at 4 C. Cells were resuspended in BSA/PBS and ana-
lyzed by flow cytometry. Nonspecific immunoglobulins of the same
isotype were used as controls. The expression of each integrin was
represented as: relative fluorescence index (RFI)  experimental mean
fluorescence/control mean fluorescence.
Western blot and immunoprecipitation
For Western blot analysis, the cells were lysed in Laemmli buffer
[0.125 mol/liter Tris (pH 6.8), 5% glycerol, 2% sodium dodecyl sulfate
(SDS), 1% -mercaptoethanol, and 0.006% bromphenol blue], and pro-
teins were resolved by 7–10% SDS-PAGE and transferred to a nitrocel-
lulose membrane (Immobilon P; Millipore Corp., Bedford, MA). Mem-
braneswere blocked by 5% nonfat drymilk, 1% ovalbumin, 5% FCS, and
7.5% glycine in PBS, washed, and incubated for 1 h at 4 C with primary
antibodies and then washed again and incubated for 1 h with a horse-
radish peroxidase-conjugated secondary antibody. Finally, protein
bands were detected by an enhanced chemiluminescence system (Am-
ersham Biosciences, Piscataway, NJ). Computer-acquired images were
quantified using ImageQuant software (Amersham Biosciences). For
immunoprecipitation, the cells were lysed in immunoprecipitation
buffer [0.05 mol/liter Tris-HCl (pH 8.0), 0.005 mol/liter EDTA, 0.15
mol/liter NaCl, 1% Nonidet P-40, 0.5% sodium deoxycolate, 0.1% SDS,
0.01 mol/liter NaF, 0.005 mol/liter EGTA, 0.01 mol/liter sodium py-
rophosphate, and 0.001 mol/liter phenylmethylsulfonylfluoride]. Rab-
bit polyclonal antibody reactive to all CaMKII isoforms (Santa Cruz
Biotechnology, Santa Cruz, CA) and protein G plus/protein A agarose
beads (Oncogene Science, Boston, MA)were used to immunoprecipitate
CaMKII from 1 mg of total lysate. Raf-1 and BRaf antibodies were from
Santa Cruz Biotechnology. Mouse monoclonal antibodies to Erk-2 and
phospho-Erk-1/2 were from Santa Cruz Biotechnology. Polyclonal anti-
phospho-CaMKII antibody (pT286-CaMKII) was from Promega (Mad-
ison, WI).
p21Ras activity assay
Ras activity was assayed by affinity precipitation using a Ras acti-
vation assay kit (Upstate Biotechnology, Lake Placid, NY). Briefly, 4 
106 cells were lysed with Mg2 lysis buffer [0.125 mol/liter HEPES (pH
7.5), 0.75 mol/liter NaCl, 5% Igepal CA630, 0.05 mol/liter MgCl2, 0.005
mol/liter EDTA, and 10% glycerol] and incubated with 5 l of a 50%
slurry of Raf-1 Ras binding domain peptide for 30 min at 4 C. The beads
were then boiled in reducing sample buffer, and adsorbed proteins were
resolved by electrophoresis, transferred to nitrocellulose, and probed
with a monoclonal anti-Ras (1 g/ml) (Mg2 lysis buffer, Raf-1 Ras
binding domain peptide, and anti-Ras were included in a Ras activation
assay kit; Upstate Biotechnology, Lake Placid, NY). Proteins were vi-
sualized using a horseradish peroxidase-conjugated secondary antibody
and enhanced chemiluminescence.
Calcium measurement
A total of 3  105 cells harvested by trypsin were loaded with cell-
permeant fura-2 acetoxymethyl ester (Molecular Probes, Eugene, OR) by
incubating the cells with DMEM, 105 mol/liter fura-2, 0.5% BSA, and
0.01 mol/liter HEPES for 30 min at 37 C. The cells were then washed
twice for 10 min with 0.001 mol/liter CaCl2 in Hanks’ balanced salt
solution [0.118 mol/liter NaCl, 0.0046 mol/liter KCl, 0.01 mol/liter
glucose, and 0.02 mol/liter HEPES (pH 7.2)]. When indicated, cells were
incubated with integrin-FN-binding arginine-glycine-aspartic acid
(RGD)-containing peptides (Gly-Arg-Gly-Asp-Ser-Pro) or control pep-
tides RGE (Gly-Arg-Gly-Glu-Ser-Pro) (Calbiochem, EMD Biosciences,
Darmstadt, Germany). Fluorescence was measured with a fluorometer
(PerkinElmer Life Sciences, Norwalk, CT). Excitation was at 345 and 380
nm and emission was at 510 nm. Minimal and maximal relative fluo-
rescences were obtained by adding 0.01 mol/liter EDTA and 2% Triton
X-100 or 0.01mol/liter EDTA, 2%TritonX-100, and 0.01mol/liter CaCl2,
respectively. The nanomolar concentration of Ca2was obtained by the
Grynkiewiez formula considering 225 Kd for fura-2 (15).
[3H]Thymidine incorporation
To determine DNA synthesis, cells were plated in F-12 , 0.5% BSA,
and 0.5 Ci [3H]thymidine in 24-well plates coated with FN. After 24 h,
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the plates were gently washedwith PBS avoiding cell loss and then with
10% trichloroacetic acid (TCA) and incubated 10 min with 20% TCA at
4 C. TCA was removed and cells were lysed with 0.2% SDS for 15 min
at 4 C. Lysates were then resuspended in 5 ml scintillation fluid and
counted in a -counter (Beckton Dickinson).
Results
Expression of FN receptors of the integrin family in thyroid
cells in culture
Follicular cells from normal glands obtained by collage-
nase digestion were cultured for a maximum of 7 d in vitro.
The expression of the FN receptors of the integrin family was
evaluated by flow cytometry with monoclonal antibodies
specific for 1-, 3, and 5-chains and for v3 and v5
heterodimers. Figure 1 reports the average expression of
integrin subunits and heterodimers measured in four differ-
ent cultures at 75% confluence. Analysis was performed on
4- to 5-d-old cultures after two passages. As previously dem-
onstrated for 31 (16), the level of v3 expression also
changed during the culture under the regulatory effect of
cell-to-cell contact. The expression of these integrins was
higher at 75% confluence than at full confluence. For this
reason all experiments were performed on cells after two
passages from 4- to 5-d-old cultures at 75% confluence. The
1- and 3-chains that associate to constitute the 31
etherodimer were strongly expressed as previously demon-
strated in normal thyroid cells in culture as well as in tissue
sections (4). The v3 receptor was expressed as previously
reported in the thyroid cell line TAD-2 (12), whereas 5 and
v5 were not expressed. Thus, normal thyroid cells in pri-
mary culture express only two integrin receptors for FN:
31 and v3.
FN activates the Ras/Erk pathway and stimulates cell
proliferation
Thyroid cells were starved from serum for 24 h, harvested,
and plated onto FN- or BSA-coated plates. Active p21Ras and
phosphorylated Erk were determined in cell extracts (Fig. 2,
A and B). Strong p21Ras activationwas achieved 15min after
plating the cells onto immobilized FN. Whereas comparable
p21Ras activation was observed at 15 and 30 min, induction
of Erk phosphorylation was slower and 30 min stimulation
was required to induce a powerful phosphorylation.Also cell
proliferation was influenced by FN. Cell number was cal-
culated after 24 and 48 h culture onto FN-coated plates in the
absence of serum (Fig. 2C).Whereas in the absence of FN and
serum cell adhesion was denied, FN alone was sufficient to
allow cell adhesion and spreading. FN induced a 60% in-
crease of cell number after 48 h, whereas the in the presence
of the Mek inhibitor PD98052, cell proliferation was com-
pletely abrogated. The number of cells plated onto BSA-
coated plates was not calculated because cell adhesion was
veryweak in the absence of serumor FN andmost of the cells
were detached by 48 h culture.
Inhibition of FN-integrin binding impairs p21
Ras activation
To determine which integrin/s generate/s the Ras/Erk
pathway, p21Ras activitywas determined in cells plated onto
FN in the presence of binding-inhibiting antibodies (Fig. 3).
An anti-v3 binding-inhibiting antibody strongly inhibited
p21Ras activation induced by FN, whereas anti-3 was in-
effective. Inhibition of p21Ras activation by anti-v3 anti-
FIG. 1. Expression of integrin FN receptors in normal thyroid cells
from primary cultures. Cells were harvested by mild trypsinization
from subconfluent cultures and incubatedwithmonoclonal antibodies
specific for single integrin subunits (1 and 5) or whole receptors
(v3 and v5) followed by the secondary fluorescein-conjugated
antibody. The relative fluorescences were measured by flow cytom-
etry as described inMaterials and Methods in different cultures. The
expression of each integrin etherodimer or single subunit is reported
as: RFI experimentalmean fluorescence/controlmean fluorescence.
FIG. 2. Activation of the Ras/Erk pathway and stimulation of cell
proliferation by FN. Cells were harvested by trypsinization from
subconfluent cultures and plated ontoBSA- or FN-coated plates. After
the indicated time, the cells were lysed. A, Activated p21Ras was
immunoprecipitated with Raf-1 Ras binding domain peptide-conju-
gated agarose beads and visualized by Western blot (active-p21Ras),
and total Ras in cell extracts was visualized byWestern blot (p21Ras).
B, The extracts were analyzed by Western blot with antiphosphoty-
rosine-Erk (p-Erk-1, p-Erk-2) or anti-total-Erk-2 (Erk-2) antibodies.
C, Fifty thousand cells were plated in serum-free medium onto FN-
coated plates with or without 20 M PD98052. After 24 and 48 h, the
cells were harvested and counted by a hemocytometer.
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bodies was not complete. Although this could be explained
by incomplete inhibition of FN-v3 binding, participation
of other factors (other adhesion molecules or FN contami-
nants) in the p21Ras activation is possible. These data suggest
that the integrin v3 participates in the activation of the
Ras/Erk signal pathway in normal human thyroid cells.
Activation of the integrin v3 induces increase of
intracellular calcium concentration
To test whether integrin activation by FN also generates a
calcium signal, intracellular free calcium concentration
([Ca2]i) was measured by fluorometric analysis in cells in
suspension in response to soluble FN binding (Fig. 4). Cells
were incubated with soluble FN in the presence of peptides
inhibiting the integrin-FN binding (RGD) or control peptides
(RGE), anti-v3, or nonrelevant antibodies. After 30 min of
suspension, FN plus peptides or antibodies were added to
the cells. In the cells treatedwith FN alone or FN plus control
peptide (not shown), [Ca2]i increased, reaching a 4-fold
increase by 60min. The FN receptor antagonist peptide RGD
completely inhibited the [Ca2]i increase, demonstrating that
FN effect wasmediated by integrins. The anti-v3 antibody
inhibited the [Ca2]i increase induced by FN, whereas a
control antibody was ineffective. These data suggest that FN
activates a Ca2 signal through the integrin v3.
Integrin binding to FN induces CaMKII activation
To determine whether the FN-induced [Ca2]i increase
could activate CaMK enzymatic activity, we evaluated the
phosphorylation level of CaMKII (Fig. 5). CaMKII autophos-
phorylation at T286 residue indicates CaMKII activation.
Serum-starved cells were plated onto FN or BSA, and
CaMKII T286-phosphorylation was evaluated by Western
blot. In the absence of FN no signal was visible by antiphos-
phothreonine CaMKII antibody at any time. After 15 min of
FN stimulation, a sharp band that increased by 30 min stim-
ulation was visible, thus demonstrating that cell binding to
FN induces CaMKII activation in thyroid cells.
Inhibition of the Ca2/CaMKII pathway inhibits
FN-induced Erk phosphorylation
We previously demonstrated that in an immortalized thy-
roid cell line, Erk phosphorylation induced by FN requires
both Ras/Raf-1/Mek and Ca2/CaMKII signals. To inves-
tigate whether this is a general mechanism or it is restricted
to that specific cell type, we tested the effects of Ca2/
CaMKII pathway inhibitors on the phosphorylation of Erk
after FN binding. To perform this analysis, we used the CaM
inhibitors (W7 and TFP), the nonisoform specific CaMK in-
FIG. 3. Inhibition of FN-induced p21Ras activation by antiintegrin
antibodies. Cells were harvested by trypsinization from serum-
starved cultures and plated onto BSA- or FN-coated plates. Cells were
preincubated for 30 min with 12 g/ml of antiintegrin antibodies
inhibiting binding to FN (Ab-v3, Ab-3) or nonrelevant antibody
(Ab-CTRL). After 30 min, p21Ras activity was determined as de-
scribed. Relative expression of activated p21Ras was determined by
scanning densitometry in three independent experiments. A value of
1 OD arbitrary unit was assigned to BSA point. Results are presented
as mean  SD. *, Significant vs. CTRL point. CTRL, Control.
FIG. 4. Activation of integrin v3 by FN induces a Ca2 signal. The
cells were serum starved for 24 h, harvested by trypsin, washed with
culture medium, and loaded with fura-2. At the time indicated by the
arrow, soluble FN alone or with integrin binding inhibitor (RGD) or
control peptide (RGE), anti-v3 or nonrelevant (anti-CTRL) anti-
bodies were added to the cells, and [Ca2]i was measured by fluoro-
metric analysis. Results are presented as mean  SD nanomolar
concentration of Ca2 from quadruplicates. CTRL, Control.
FIG. 5. CaMKII phosphorylation in response to FN stimulation.
Serum-starved cells were seeded onto FN- or BSA-coated plates in the
absence of serum and analyzed by Western blot. Total CaMKII and
phosphorylated T286-CaMKII (p-CaMKII) were visualized by specific
monoclonal antibodies. Averages and SD of relative expressions of
phosphorylated CaMKII were also determined by scanning densi-
tometry of three immunoblots. In each diagram, a value of 1 OD
arbitrary unit was assigned to 0 point.
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hibitor (KN93), and a CaMKII-specific inhibitor (ant-CaN-
tide). This short peptide is derived from the endogenous
CaMKII inhibitor-protein CaMKIIN and was made cell per-
meable by the Antennapedia N-terminal sequence. The cells
were plated onto immobilized FN with different inhibitors
and the level of Erk-1/2 phosphorylation was evaluated by
Western blot (Fig. 6). Erk-1/2 phosphorylation induced by
FNwas higher than that induced by 10%FCS. KN93,W7, and
TFP displayed a dose-dependent inhibitory effect on Erk-1/2
phosphorylation. Ant-CaNtide abolished FN-induced Erk-
1/2 phosphorylation at a 5 m concentration. These data
demonstrate that Erk phosphorylation is dependent on
CaMKII activation. Thus, the requirement of Ca2/CaMKII
signals in the FN-induced Erk activation is not a feature
restricted to a cell line but is a general mechanism in thyroid
cells.
FN induces Raf-1/CaMKII association
To determine whether the interaction of Ras/Raf-1/Mek
andCa2/CaMKII signals occurs at the Raf-1 level, we tested
whether CaMKII formed with Raf-1 a multiprotein complex.
CaMKII was immunoprecipitated in extracts from cells
plated onto BSA or FN. Immunoprecipitated CaMKII and
coprecipitated Raf-1 were detected by Western blot by spe-
cific antibodies (Fig. 7). Coimmunoprecipitated Raf-1 was
visible only in cells stimulated with FN. The CaMK inhibitor
KN93 and the CaMKII inhibitor ant-CaNtide completely in-
hibited the FN-induced Raf-1/CaMKII association. This ex-
periment suggests that FN induces Raf-1 andCaMKII to form
a protein complex that depends on CaMKII activation.
BRaf/Raf-1 heterodimerization induced by FN
BRaf overexpression obtained by transfection in human
embryonic kidney cells suggested that Ras induces the Raf-
1/Braf heterodimerization through the exposure of 14–3-3
binding sites in the COOH terminus of Raf-1 (17). Thus, BRaf
heterodimerized with Raf-1 may cooperate with Raf-1 in
cellular response to FN. BRaf appears largely expressed in
thyroid cells analyzed by Western blot (Fig. 8A). To deter-
mine whether BRaf heterodimerized with Raf-1 in the
CaMKII/Raf-1 complex induced by FN, the cells were plated
onto FN, and CaMKII was immunoprecipitated. Coprecipi-
tated Raf-1 and BRaf were detected by Western blot by spe-
cific antibodies (Fig. 8B). Whereas Raf-1 was evident in FN-
induced CaMKII coprecipitate, a band for BRaf was barely
visible. These results do not support a significant role for
BRaf in the signal generated by FN-integrin binding in thy-
roid cells.
Inhibition of CaMKII blocks FN-induced
thymidine incorporation
[3H]thymidine incorporation was used to measure the
DNA synthesis in thyroid cells cultured in serum-free me-
FIG. 6. Inhibition of the Ca2/CaMKII pathway blocks FN-depen-
dent Erk phosphorylation. Serum-starved cells were plated for 30min
in uncoated plates in the presence of 10% FCS or in serum-free
medium onto BSA-coated plates or in FN-coated plates with or with-
out KN93, W7, TFP, or ant-CaNtide. Cell extracts were analyzed by
Western blot with antiphosphotyrosine-Erk-1/2 (p-Erk) or anti-total-
Erk-1 (Erk-1) antibodies. Averages and SD of relative expressions of
phosphorylated Erk1/2 were also determined in three immunoblots.
A value of 1 OD arbitrary unit was assigned to untreated point.
FIG. 7. FN induces CaMKII binding to Raf-1. The cells were plated
for 30 min onto BSA- or FN-coated plates in serum-free medium
without or with KN93 or ant-CaNtide. Cell extracts were immuno-
precipitated with a specific anti-CaMKII antibody. After protein sep-
aration by SDS-PAGE and transfer to a nitrocellulose membrane,
immunoprecipitated CaMKII and coprecipitated Raf-1 were detected
by anti-CaMKII and anti-Raf-1 antibodies, respectively.WB,Western
blot.
FIG. 8. BRaf coprecipitation with the CaMKII/Raf-1 complex. A,
Raf-1 and BRaf in total cellular extracts were visualized by Western
blot with specific antibodies. B, The cells were plated for 30 min onto
BSA- or FN-coated plates in serum-free medium. Cell extracts were
immunoprecipitated with a specific anti-CaMKII antibody. After pro-
tein separation by SDS-PAGE and transfer to a nitrocellulose mem-
brane, immunoprecipitated CaMKII and coprecipitated Raf-1 and
BRaf were detected by specific antibodies. WB, Western blot.
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dium on immobilized FN or untreated wells for 24 h (Fig. 9).
In the absence of FN, cells wereweakly attached to the plates,
round shaped, and spreading was limited by 24 h. In FN-
coated wells, the cells were well adherent and flat shaped.
The presence of inhibitors did not change the attachment,
shape, or spreading. The FN stimulation induced 66% in-
crease of [3H]thymidine incorporation. Both KN93 and ant-
CaNtide completely abolished such stimulation, demonstrat-
ing that FN-induced DNA synthesis requires CaMKII
activity.
Thyroid cancer cells display aberrant integrin expression
and signaling
The surface expression of integrin receptors for FN was
determined in a cell line originated from normal thyroid
(TAD-2), and cell lines originated from papillary carcinomas
(NPA and TPC-1). Although thyroid cancer cells have a
broad pattern of integrin expression (18), within FN recep-
tors only quantitative changes of 31 and v3were found,
and de novo expression of v5 was not observed (Fig. 10A).
Because integrin expression is regulated by several factors,
data in cultured cells must be confirmed by tissue analysis.
Immunohistochemistry with anti-v3 antibodies con-
firmed altered expression of this integrin in papillary carci-
nomas (Fig. 10B). As for cell lines, the level of v3 expres-
sion was demonstrated to be variable. To evaluate the signal
response to FN, the cells were plated onto immobilized FN
with or without CaMK inhibitor, and the level of Erk-1/2
phosphorylation was evaluated by Western blot (Fig. 9B).
Erk-1/2 phosphorylation was induced in TAD-2 cells and
inhibited by KN93 as previously demonstrated (11). In un-
stimulated papillary carcinoma cell lines, Erk-1/2 was phos-
phorylated and FN stimulation did not produce any change.
CaMKII inhibition by KN93 decreased Erk-1/2 phosphory-
lation in TPC-1 cells, whereas it was ineffective in NPA cells.
The explanation for the insensitivity to CaMK inhibition in
NPA cells lies in the presence of BRafVal599 oncogene (19) that
is independent from CaMKII activation (our unpublished
data).
Discussion
We recently demonstrated that integrin activation in the
TAD-2 cell line generates three distinct signals: Fak/Ras/
Mek/Erk, Ca2/CaMKII, and PI-3K signal (10, 11). In the
same studies, we also provided evidence that the Ca2/
CaMKII signal is necessary to Raf-1 activation by Ras in the
Fak/Ras/Mek/Erk pathway. Although TAD-2 cells repre-
sent a reliable human thyroid cell model to study integrins
and thyroid ECM interaction, it was generated from fetal
thyroid cells by Simian virus 40 infection. Thus, a direct
demonstration of the signals generated by integrin activation
by FN and their role in the control of proliferation in primary
thyroid cells in cultures was not yet provided.
Within integrins, the two FN receptors,51 andv3, are
recognized to be important for generating signals that drive
proliferation, survival, and spreading (20–23). Previous
studies demonstrated that thyroid cells do not express 51
or v5, whereas they express v3 and minimal v1 in
certain conditionedmedium (24, 25).Within the FN receptors
expressed in thyroid cells, 31 is likely to play only a struc-
tural role because its signaling capacity is not yet established,
whereas v3 has a recognized signaling function (8, 26–28).
The complexity and tissue specificity of signaling generated
in response to integrin engagement is made possible by the
complexity of interactions betweenmultiple factors that take
place in the focal adhesion. In response to 51 and vb3
engagement, the Ras/MAPK signal pathway is activated
through the adapter molecules Shc and Grb2/Sos involving
FAK, paxillin, or c-Srk in fibroblasts and epithelial and en-
dothelial cells (29–31). Thyroid cells cultured in vitro in me-
dium also containing hypothalamus and pituitary extracts
express v3 integrin in a latent state characterized by its
inability to cluster at focal adhesions and promote cell ad-
hesion. However, v3 recruitment at focal adhesions and
ligand-binding activity occurred on treatment with hepato-
cyte growth factor/scatter factor (25). In the normal thyroid
cell line TAD-2, v3 membrane expression is restricted to
focal adhesions, whereas in the present study, in normal
thyroid cells cultured in the absence of growth factors, v3
stained by immunofluorescence displayed a fine grainy pat-
tern of distribution (not shown). This membrane localization
not restricted to focal adhesions suggests the possibility that
the effect measured in our system might be of a higher
magnitude in a more physiological environment in the pres-
ence of those endocrine and paracrine factors abundant in
vivo. All together these data indicate that culture conditions
and growth factors are relevant modulators of expression
and function of integrins in thyroid cells and that normal
thyroid cells potentially express active v3 integrin.
Cell proliferation is regulated by converging signals on the
cell cycle machinery that determine whether the cell stays in
theG1 phase or proceeds to S phase. The progression through
G1 into the DNA synthesizing S phase is driven by cyclin-
dependent kinase (CDK)4 andCDK6,which interactwith the
cyclin D family of proteins, and CDK2, which interacts with
cyclins A/E (32). The Ras/Raf/Mek/Erk cascade plays a
FIG. 9. Stimulation of thymidine incorporation by FN requires
CaMKII activity. Thyroid cells were seeded in microtiter plates pre-
viously coated by overnight incubationwith 10g/ml FN inPBS.Cells
were cultured for 24 h in serum-free medium, with 0.5 Ci [3H]thy-
midine in the presence of 0.01 mol/liter KN93 or 0.005 mol/liter ant-
CaNtide where indicated. Data are reported as mean  SD of qua-
druplicate experiments. *, Significant vs. CTRL point. **, Significant
vs. FN point, not significant vs. CTRL.
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pivotal role in the control of this process. Sustained Erk
activation is required to pass the G1 restriction point and
regulate cyclin D1 expression during mid-G1 phase (33).
Inhibition of FN-stimulated proliferation by Mek inhibitor
demonstrates the role of Erk in this process in thyroid cells.
In normal cells, it is unlikely that integrin might sustain
prolonged proliferation in the absence of other growth fac-
tors. This topic may not be investigated in primary cultures
of thyroid cells because they have a very limited growth
potential. Our results demonstrate the involvement of v3
and the Ras/Erk signal in FN-stimulated proliferation in
culture, whereas in vivo the entire pathway or part of it must
be abrogated or counteracted. Integrins are constantly en-
gaged by the ECM of the basal lamina surrounding the thy-
roid follicles. Thus, whereas the PI-3K signal might be con-
tinuous and relevant in survival, the Ras/Erk signal must be
downmodulated to avoid aberrant stimulation of prolifera-
tion. Thyroid-stimulating hormone that has been proposed
to inhibit Ras signaling to Raf/MAPK might represent one
of these factors (34, 35).
Although this and other factors might be responsible of
such a regulation, the complexity of signals generated by
integrins makes possible their self-modulation. Within sig-
nals generated by integrins, PI-3K/Cdc42/Pak represents a
costimulatory signal that modulates the Ras/Erk pathway.
In COS-7 cells, PI-3K inhibition induces severe attenuation of
integrin-dependent Erk activation (36). Integrin-FN binding
activates the serine/threonine kinase Pak through PI-3K and
Cdc42. Pak thenphosphorylates Raf-1 on Ser338, ensuingErk
activation by Ras (36, 37). Whereas Ser338-Raf-1 phosphor-
ylation is necessary for Raf-1 to be fully activated by Ras (38,
39), integrins are not the sole activators of Pak-1, and in any
FIG. 10. Aberrant integrin expression and signaling in thyroid cancer cells. A, Cells were harvested by mild trypsinization, stained by indirect
immunofluorescence with monoclonal antibodies, and relative fluorescences were measured by flow cytometry. The expression of each integrin
etherodimer or single subunit is reported as: RFI  experimental mean fluorescence/control mean fluorescence. B, Immunohistochemical
analysis of integrin v3 expression in normal thyroid and in papillary cancer. The staining was equally developed in all follicles in normal
thyroid samples (N). The v3 expression displayed a variable degree of intensity in papillary carcinomas, being from faint to intense (P1-P3).
C, Serum-starved cells were plated in serum-freemedium for 30min onto BSA-coated plates or in FN-coated with or without KN93. Cell extracts
were analyzed by Western blot with antiphosphotyrosine-Erk-1/2 (p-Erk) or anti-total-Erk-1 (Erk-1) antibodies.
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system Pak-1 is not always necessary for Raf-1 activation,
possibly because it is substituted by other factors. Indeed,
Pak-1 inhibition in Rat-1 fibroblasts abrogates Ras-induced
transformation, whereas it is ineffective in NIH-3T3 fibro-
blasts in which other factors must coactivate Raf-1 (40, 41).
Also in TAD-2 cells, FN binding induces a modest level of
Pak-1 phosphorylation whose role was not investigated (11).
In TAD-2 cells and primary thyroid cultures, besides the
Ras/Erk signal, integrin engagement activates the Ca2/
CaMKII signal. CaMKII and Ras are both necessary to acti-
vate Raf-1, and inhibition of CaMKII abrogates Erk phos-
phorylation and proliferation induced by FN. Thus, integrins
can self-modulate their own proliferation signal through the
PI-3K/Pak-1 and Ca2/CaMKII signals. Coimmunoprecipi-
tation experiments demonstrate that CaMKII and Raf-1 par-
ticipate in a common multiprotein complex. The question
whether Raf-1 is a direct CaMKII substrate was not ad-
dressed in this study. However, this is a possibility worthy
of consideration becauseRaf-1 is a substrate formany kinases
and presents a number of consensus sequences for CaMKII.
The malignant behavior of cancer cells is determined by
not simply uncontrolled growth but also the ability to mi-
grate, proliferate, and survive in denied adhesion or ectopic
body districts. Tumor cells metastasized into ectopic sites or
moving in the vascular or lymphatic system loose adhesion
to the basal lamina mediated by integrins. The adhesion
receptors expressed on the surface of invading cells play a
fundamental role in this process. Changes in the level of
surface expression of integrins or de novo expression or ac-
tivation state occur in a number of neoplastic lesions includ-
ing thyroid cancer (18, 42–46). The two thyroid cancer cell
lines we examined in this study displayed aberrant integrin
expression, and Erk resulted in a phosphorylated state also
in denied adhesion. Independently whether Erk activation
resulted from activated integrins, oncogenes, or other acti-
vating pathways, aberrant integrin expression and activation
might still play a relevant role as a costimulatory factor. In
TPC-1 cells the Ca2/CaMKII signal is still necessary to Erk
phosphorylation. In this cell line harboring RET/PTC-1, this
oncogene might be responsible of sustained Erk phosphor-
ylation, and CaMKII can be activated by integrins or other
effectors including RET/PTC-1 oncogene. Conversely, tu-
mor cells harboring oncogenes that do not lie on the tyrosine
kinase/Raf-1 pathway elude the Raf-1/CaMKII checkpoint.
The mutation at site T1796 is sufficient to generate a BRaf
mutant constitutively activated (47). One relevant difference
between Raf-1 and BRaf is the presence of the S445 in BRaf.
This serine is equivalent to S338 of Raf-1 and is constitutively
phosphorylated (39). Also for this reason, Ras alone is suf-
ficient to activate BRaf and Val599E mutation activates BRaf
with no need for other factors. A number of biological con-
sequences with clinical relevance arise from the Raf-1/
CaMKII interaction. Future studies must determine the fac-
tors responsible for CaMKII activation in tumors. Besides
altered integrins and known physiological factors, mutated
Ras, Trk, and RET/PTC have the potentiality to autono-
mously activate the Ca2/CaMKII signal. A different ability
to activate CaMKII might be responsible for the different
aggressive behavior observedwithin RET/PTCmutants and
different oncogenes.
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ABSTRACT 1 
The pleiotropic effects of insulin include cellular growth and glucose synthesis and uptake. These events are regulated by multiple signals generated by the 
insulin receptor. The mechanisms of individual modulation of these signals remain somewhat elusive. We investigated the role of CaMKII in insulin signaling 
in a rat skeletal muscle cell line, demonstrating that CaMKII modulates the stimulation of the DNA synthesis and the negative feedback that down regulates 
glucose uptake.  
Insulin stimulation generated partly independent signals leading to the activation of Akt, Erk-1/2 and CaMKII. Phosphorylation of these three kinases and IRS-
1/p85PI3K association began by 5  min stimulation. By 30 min IRS-1 was phosphorylated at S612, the IRS-1/p85PI3K complex was disrupted and Akt was no 
more phosphorylated. Akt activation was followed by Glut-4 translocation to the plasma membrane and increase of glucose uptake. Then, both Glut-4 
translocation and glucose uptake were reduced. Insulin, promoted CaMKII association with Raf-1 and inhibition of CaMKII abrogated the insulin-induced Erk-
1/2 activation, thymidine incorporation and the phosphorylation of IRS-1 at S612. Inhibition of CaMKII also abrogated the down-regulation of insulin-
stimulated Akt phosphorylation, Glut-4 membrane translocation and glucose uptake. 
These results demonstrate that CaMKII promotes insulin-induced Erk-1/2 activation and cell proliferation, while attenuating the IRS-1/Akt pathway and 
promoting the down-regulation of stimulated glucose uptake. This represents a novel mechanism in the selective control of insulin signals, and a possible site 
for pharmacological intervention.  
 
 3
INTRODUCTION 
 
Insulin has both metabolic and mitogenic effects in several cell mammalian cell types. It modifies the expression or the activity of a variety of enzymes and 
transport systems, stimulates glucose influx and metabolism in muscle cells and adipocytes, and inhibits gluconeogenesis in the liver. Insulin, also stimulates 
the proliferation of a variety of cells, and a number of evidences suggest that it is also an important regulator of growth in vivo. The capability of the insulin 
receptor to regulate such different functions depends upon its ability to generate a number of different intracellular signals including those involving Akt, 
mitogen activated protein kinase, protein kinase C (PKC) and Ca2+. It remains to be determined how all these signals are individually modulated to respond to 
environmental stimuli and cellular requirements. The insulin receptor is a transmembrane glycoprotein with intrinsic protein tyrosine kinase activity, modulated 
by insulin binding through phosphorylation of the receptor itself. Direct substrates of the insulin receptor are the insulin receptor substrates 1 and 2 (IRS-1 and 
IRS-2) (1). After insulin binding, the major substrate IRS-1 is phosphorylated in several tyrosine residues (2-5). Phosphorylation of these tyrosines is required 
to bind the p85 subunit of PI3-kinase (PI3-K) and the subsequent Akt activation. Insulin binding to its receptor activates different pathways that can signal to 
the nucleus, including extracellular-regulated kinase (Erk-1/2) (6, 7). Notably, the insulin receptor can regulate its own signal through a negative feedback loop 
involving Erk-1/2 and Grb-2 associated binder 1 (Gab1). In CHO cells and in the human kidney fibroblast cell line 293, PKC activation results in decreased 
insulin-stimulated IRS-1 association with PI3-K and subsequent Akt activation (8). This inhibition was found to correspond to phosphorylation of the serine 
612 in IRS-1 by Erk-1/2. Phosphorylation of IRS-1 at serine 612 by Erk-1/2 appears to inhibit phosphorylation at tyrosine 608, the major PI3-K binding site (8-
10). More recently, liver knockout Gab1 mice demonstrated that Gab1 mediates insulin-stimulated Erk-1/2 activation (11). This scaffolding adaptor protein, 
while reducing insulin-stimulated glucose metabolism in the liver, promotes hepatocyte proliferation induced by insulin. Thus, Erk-1/2 or Gab1 modulators can 
enhance or reduce glucose uptake and metabolism in the liver and participate to glucose homeostasis. By this mechanism, insulin induced effects can be 
modulated by the receptor itself or by endogenous or environmental interfering factors.  
The role played by Ca2+ in insulin signaling has long been debated, and remains still partly unsolved. Indirect evidences suggest that Ca2+ is involved in insulin 
action, as its chelation reduces insulin stimulation of glucose uptake (12). Noteworthy, insulin does not induce a significant increase of the cytoplasmic 
intracellular calcium concentration [Ca2+]i in skeletal muscle cells, however it increases the near-membrane free Ca2+ concentration with a mechanism mediated 
by PI3-K, involving L-type Ca2+ channels (13, 14). An important mediator of Ca2+ signal is the calcium calmodulin-dependent kinase II (CaMKII). CaMKII is a 
ubiquitous serine-threonine kinase that phosphorylates a large number of substrates (15, 16). Several isoforms exist of CaMKII derived from alternative 
splicing, some located in the cytoplasm, others in the nucleus (17). In the cytoplasm, there is an extensive cross-talk between CaMKs and other signaling 
cascades, including those that involve the cAMP-dependent kinase (PKA), Erk-1/2 and Akt (18-20). 
CaMKII modulates the integrin signal in thyroid cells (18, 21). CaMKII binding to Raf-1 is necessary to Raf-1 activation by Ras, thus modulating the 
Ras→Raf-1→Mek→Erk-1/2 pathway generated by fibronectin-dependent integrin activation in this cell type (18). To determine the relevance of the 
CaMKII/Erk-1/2 interplay in other models, we extended our study to the insulin signaling in a rat skeletal muscle cell line (L6) stably expressing the human 
insulin receptor, and in human fibroblasts. We provided experimental evidences for a novel role of CaMKII in the insulin signaling cascade. According to our 
results, insulin-activated CaMKII promotes Erk-1/2 phosphorylation and cell proliferation, while attenuating the IRS-1/Akt pathway promotes the down-
regulation of stimulated glucose uptake. This represents a novel mechanism in the selective control of insulin signaling. 
  
MATERIALS AND METHODS 
 
Cell cultures 
The L6 skeletal muscle cells were grown in Dulbecco modified eagle medium (DMEM) (Life Technologies, Inc, Grand Island, NY) supplemented with 10% 
fetal calf serum (Sigma, St. Louis, MO) and 2% glutamine, in a humidified CO2 incubator by the method of Caruso et al. (22).  
 
Calcium Measurement 
Fluorimetric analysis: A total of 3x105 cells harvested by trypsin were loaded with cell-permeant Fura-2 acetoxymethyl ester (Molecular Probes, Eugene, OR), 
by incubating the cells with Dulbecco’s modified Eagle’s medium, 10-5 mol/L Fura-2, 0.5% BSA, and 0.01 mol/L HEPES for 30 min at 37 C. The cells were 
then washed twice for 10 min with 0.001 mol/L CaCl2 in Hanks’ balanced salt solution (0.118 mol/L NaCl, 0.0046 mol/L KCl, 0.01 mol/L glucose, and 0.02 
mol/L HEPES, pH 7.2). Fluorescence was measured with a fluorimeter (PerkinElmer Life Sciences). Excitation was at 345 and 380 nm, emission was at 510 
nm. Rmin and Rmax were obtained by adding 0.01 mol/L EDTA and 2% Triton X-100 or 0.01 mol/L EDTA, 2% Triton X-100, and 0.01 mol/L CaCl2, 
respectively. The nanomolar concentration of Ca2+ was obtained by the Grynkiewiez formula considering a 225 KDa for Fura-2 (23).  
For calcium transients imaging, 200.000 cells were plated onto a 60 mm microscope dish, starved o.n., and loaded with 12.5 mg Oregon green /100 μl of 
Standard Buffer (in mM: 137 NaCl; 2.7 KCl; 1 Na2HPO4; 20  Hepes, 7.4 pH; 1 MgCl2; 2 CaCl2; 2.5 Glucose) for 30 min at 37 C. The cells were then washed 
once with Standard Buffer, and acquisition started in 500 μl standard buffer. For stimulation, insulin was used at 100 nM final concentration. Cytosolic Ca2+ 
changes were detected using a cooled CCD camera (Coolsnap HQ, Princeton Instruments, Inc., Trenton, NJ) mounted on a Zeiss Axiovert 200 microscope with 
a Plan-Neofluar 63 x/1.25 Oil objective. The quantified Ca2+ signal was normalized to the baseline fluorescence (F0) following the formula Relative 
fluorescence = [F-F0]/F0, where F represents the average fluorescence level of the region of interest at a given time point. Fluorescent Ca2+ images were 
analyzed with the MetaMorph Imaging System software (Universal Imaging Corporation, West Chester, PA). 
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Western blot and immunoprecipitation procedures 
For Western blot analysis, the cells were lysed in Laemmli buffer (125 mM Tris, pH 6.8, 5% glycerol, 2% SDS, 1% β-mercaptoethanol, and 0.006% 
bromphenol blue), and proteins were resolved by SDS-PAGE and transferred to a nitrocellulose membrane (Immobilon P; Millipore Corporation, Bedford, 
MA). Membranes were blocked by 5% nonfat dry milk, 1% ovalbumin, 5% FCS, and 7.5% glycine, washed and incubated for 1 h at 4°C with primary 
antibodies, then washed again and incubated for 1 h with a horseradish peroxidase-conjugated secondary antibody. Finally, protein bands were detected by an 
enhanced chemiluminescence system (ECL, Amersham Biosciences). Computer-acquired images were quantified using ImageQuant software (Amersham Bio-
sciences). For immunoprecipitation, the cells were lysed in immunoprecipitation buffer (50 mM Tris-HCl, pH 8.0, 5 mM EDTA, 150 mM NaCl, 1% Nonidet P-
40, 0.5% sodium deoxycolate, 0.1% SDS, 10 mM NaF, 5 mM EGTA, 10 mM sodium pyrophosphate, and 1 mM phenylmethylsulfonylfluoride). Rabbit 
polyclonal antibody reactive to all CaMKII isoforms (Santa Cruz Biotechnology, Santa Cruz, CA), Raf-1 (Santa Cruz Biotechnology), and protein G 
plus/protein A agarose beads (Oncogene Science, Boston, MA) were used to immunoprecipitate corresponding proteins from 1 mg of total lysate. Non-immune 
rabbit IgG were also used as a control. Mouse monoclonal antibodies to p44/p42 MAPK and phospho-p44/p42 MAPK were from Santa Cruz Biotechnology. 
Polyclonal anti-phospho-CaMKII antibody (pT286-CaMKII) was from Promega (Madison, WI). Anti-IRS-1 and phospho-Ser612-IRS1 mouse monoclonal 
antibodies were from Cell Signaling Technology, Danvers, MA. 
 
[3H]thymidine incorporation 
To determine DNA synthesis, cells were plated in 24-well plate, and serum-starved for 48 hours in DMEM, 0.5% BSA. 0.5 μCi [3H]thymidine and 100nM 
insulin were then added to the plates. After 24 h, the plates were gently washed with PBS and then with 10% trichloroacetic acid (TCA), and incubated 10 min 
with 20% TCA at 4°C. TCA was removed and cells were lysed with 0.2% SDS for 15 min at 4 C. The lysates were then resuspended in 5 ml scintillation fluid 
and counted in a β-counter (Beckton Dickinson). 
 
CaMKII activity and inhibitors 
The cells were lysed in 200 µl of RSB buffer (24) with 10 mM CHAPS and 20 µl of the extracts were assayed in 50 µl of reaction mixture consisting of 50 mM 
HEPES pH 7.5, 10 mM MgCl2, 0,5 mM dithiothreitol (DTT), 2µM CaM, 100 nM microcystin, 50 µM ATP (1500 cpm/pmol [γ32P]ATP), and 0,1 mM of 
substrate peptide Autocamtide II(24). Total CaMK activity was determined by including 1 mM CaCl2 in the mixture, while autonomous activity was measured 
in the presence of 2.5 mM EGTA. Ionomycin (Sigma) at a concentration of 500 ng/mL was used as a positive control for CaMKII activation. The reaction was 
carried out for 2 minutes at 30 °C and 20 µl aliquots of the reaction mixture were spotted onto p81 phosphocellulose filters (Upstate Biothechnology, Lake 
placid, NY) as described previously (25). Purified CaM and autocamtide II were a kind gift from Dr. AR. Means, Durham, NC. The CaMK inhibitor KN93 and 
the CaM inhibitors trifluoperazine (TFP) and N-(6-aminohexyl)-5-chloro-1-nafthalene-sulfonamide (W7) were purchased from Sigma. The CaMKII specific 
inhibitor ant-CaNtide is derived from the endogenous CaMKII inhibitor protein CaMKIIN (26, 27) and was made cell permeable by N-terminal addition of an 
antennapedia-derived sequence (ant-CaNtide:  
RQIKIWFQNRRMKWKKRPPKLGQIGRSKRVVIEDDRIDDVLK) (28). The reversed ant-CaNtide peptide was also used as a control. Both peptides were 
synthesized by L. D’A. 
 
Raf-1 activity assay 
Raf-1 activity was evaluated by a Raf-1 immunoprecipitation-kinase cascade assay kit (Upstate Biotechnology). Briefly, Raf-1 was immunoprecipitated from 1 
mg of cell extracts. The immunocomplexes were washed and incubated in the presence of magnesium/ATP, inactivated Mek-1, and Erk-2 for 30 min at 30 °C. 
An aliquot of the mixture was then incubated with 20 μg of myelin basic protein (MBP) in the presence of [γ-32P]ATP. The reaction was quenched with 
Laemmli buffer, and proteins were separated through a 10% polyacrylamide/tris glycine gel. Radioactive-phosphorylated MBP on dried gels was quantified 
with the use of a Phosphor- Imager (Amersham Biosciences). 
 
Cell membrane expression of Glut-4 
 
Glucose uptake 
Confluent cells were incubated in DMEM supplemented with  0.25% albumin for 18 h at 37°C. The medium was aspirated and cells were further incubated for 
30 min in glucose-free HEPES buffer (5 mmol/l KCl, 120 mmol/l NaCl, 1.2 mmol/l MgSO4, 10 mmol/l NaHCO3, 1.2 mmol/l KHPO4, and 20 mmol/l HEPES, 
pH 7.8, 2% albumin). The cells were incubated with 100 nmol/l insulin for convenient time, supplemented during the final 10 min with 0.2 mmol/l [14C]2-D-
glucose. Cells were then solubilized and the 2-D-glucose uptake was quantified by liquid scintillation counting. 
 
Statistical analysis 
Results are presented as the mean ± SD. Statistical analysis was performed by using the t test. The level of significance was set at P less than 0.05. 
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RESULTS 
 
Insulin induces Akt, Erk-1/2 and CaMKII phosphorylation in L6 cells. 
L6 cells starved from serum were stimulated with Insulin for 5 to 120 min, lysed and Erk-1/2, Akt and CaMKII phosphorylation were evaluated by Western blot 
with a phospho-specific antibody (Fig. 1A). Although overnight starvation was maximal and longer starvation would result in loss of cell viability, a band 
obtained by Erk-1/2 phospho-specific antibody was always consistent, suggesting that serum starvation was incomplete or that non-serum factors (i.e. integrins 
engagement, autocrine factors) are responsible for a constitutive low-activation state of Erk-1/2 in L6 cells. Insulin stimulation induced Erk-1/2 CaMKII 
phosphorylation yet at 5 min and both the kinases remained phosphorylated up to 120 min. As observed in other cell types (9) after an initial increase, Akt 
phosphorylation resulted down-regulated. Phosphorylation of Akt occurred at 5 min and the kinase was no more phosphorylated by 30 min of insulin 
stimulation. Akt phosphorylation occurred in a dose-dependent manner and its down-regulation was independent by the insulin concentration (Fig. 1B).  
 
Insulin stimulation induces intracellular [Ca2+]i increase and CaMKII activation. 
CaMKII is activated by its binding to Ca2+-activated calmodulin. This is the only mechanism for CaMKII activation. In order to evaluate whether insulin was 
able to initiate the cascade leading to CaMKII activation, we measured [Ca2+]i in the cells following insulin stimulation. (Fig. 2). The cells were serum-starved 
overnight, and were subsequently loaded with Fura-2, detached from the plates and examined in suspension by fluorometry (Fig. 2A). [Ca2+]i remained 
unchanged for 15 minutes in unstimulated cells. Subsequently, insulin was added at different concentrations and a [Ca2+]i increase appeared soon after 
stimulation. The [Ca2+]i increase was rather slow relative to other Ca2+ mobilizing agents and was dose-dependent upon the concentration of insulin used 
reaching about 5-fold increase by 10 min with 100 nM insulin. [Ca2+]i was then determined at single cell level by confocal microscopy in adherent cells loaded 
with Oregon Green (Fig. 2B, 2C). 100 nM insulin induced a slow increase of [Ca2+]i, confirming what observed in the same cells in suspension. Among 
CaMKs, the isoform II is ubiquitary and is involved in the control of Ras→Erk-1/2 pathway upon integrin engagement (18). To evaluate whether insulin-
stimulated [Ca2+]i  increase induced a dose-dependent CaMKII activation, we determined CaMKII phosphorylation by Western blot analysis and measured the 
kinase activity by in vitro assay. Western blot analysis displayed a faint band corresponding to activated CaMKII in unstimulated cells (Fig. 3A). Insulin 
stimulation induced a dose-dependent increase of CaMKII phosphorylation. CaMKII kinase activity was measured by the phosphorylation of its specific 
substrate autocamtide in vitro (Fig. 3B). The in vitro kinase assay confirmed what we observed by Western blot. Immunoprecipitated CaMKII from 
unstimulated cells displayed a consistent kinase activity, which was significantly increased by insulin stimulation. 
 
Insulin stimulates CaMKII association with Raf-1. 
As integrin stimulates CaMKII activation and its association with Raf-1, we investigated whether also insulin induces CaMKII/Raf-1 binding (18). A 3-fold 
increase of Raf-1 activity was observed by in vitro kinase assay in the cells stimulated with insulin, whereas it was inhibited by KN93 and antCaNtide (not 
shown). In order to determine whether CaMKII and Raf1 associated, CaMKII was immunoprecipitated from extracts of insulin-stimulated cells. 
Immunoprecipitates were analyzed by Western blot with antibodies to CaMKII and Raf-1 (Fig. 4). Raf-1 co-precipitated with CaMKII upon insulin stimulation 
and was completely inhibited by KN93 and antCaNtide. These data suggest that activated CaMKII binds to Raf-1 thus participating to the formation of a 
multimolecular complex. 
 
Inhibition of CaMKII abrogates insulin-stimulated Erk-1/2 phosphorylation and thymidine incorporation.  
A cross talk between the Ca2+/CaMKII and Erk-1/2 signaling pathways was previously demonstrated in integrin signaling. To investigate the possible existence 
of a similar cross talk in insulin signaling, we first tested the effects of CaMKII inhibitors on Erk-1/2 phosphorylation induced by insulin. A knockdown 
approach by small interfering RNA was considered. However, because multiple isoforms of CaMKII are expressed in L6 cells (not shown), pharmacological 
inhibition and highly specific inhibition of enzymatic binding site were preferred (26)(18)(27).The cells were stimulated with insulin in the presence or in the 
absence of the CaMKs pharmacological inhibitor KN93 or the cell permeant CaMKII-inhibitory peptide ant-CaNtide, and the levels of Erk-1/2 and Akt 
phosphorylation were evaluated by Western blot (Fig. 5A). Both inhibitors not only completely abolished Erk-1/2 phosphorylation induced by 30 min insulin 
stimulation but also basal phosphorylation was strongly reduced. These data suggest that in our model muscle cells, Erk-1/2 activation requires active CaMKII. 
[3H]thymidine incorporation was used to measure DNA synthesis in the cells cultured in serum-free medium stimulated with 100 nM insulin for 24 h (Fig. 5B). 
Insulin stimulation induced 65% increase of [3H]thymidine incorporation. Both KN93 and ant-CaNtide completely abolished such stimulation, demonstrating 
that insulin-induced DNA synthesis requires CaMKII activity.  
 
CaMKII is necessary for the negative-feedback of insulin-stimulated IRS-1/p85 complex and IRS-1  phosphorylation on S612. 
Erk-1/2 phosphorylates IRS-1 at Ser612 and inhibits the insulin-stimulated binding of IRS-1 to PI3-K, thus down-regulating AKT activation (8). Based on our 
results, CaMKII inhibition was expected to suppress IRS-1 phosphorylation at Ser612, down-regulation of IRS-1/PI3-K binding and AKT dephosphorylation. 
The cells were stimulated with insulin for 5 up to 120 min and then IRS-1 was immunoprecipitated. After protein separation, the phosphorylation at Ser 612 or 
the p85 subunit of PI3-K bound to IRS-1 were detected by Western blot with specific antibodies. Co-precipitated p85 appeared by 15 ATTENZIONE 
VERIFICARE SE AKT SI ATTIVA A 5 MIN. DEVE ESERE UGUALE ALL’ATTIVAZIONE DI AKT min of insulin stimulation and disappeared by 30 min 
(Fig. 6A). IRS1 was phosphorylated at Ser612 by 30 min and it remained phosphorylated up to 120 min (Fig 6B). Both KN93 and antCaNtide completely 
abrogated phosphorylation of S612 IRS-1. By 15 min of insulin stimulation, the association of IRS-1 and p85 was consistently increased by CaMKII inhibitors. 
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CaMKII inhibition also preserved the IRS-1/p85 complex after 30 min and up to 120 min of insulin stimulation. These results indicate that CaMKII is necessary 
for Erk-1/2 activation that in turn phosphorylates S612 IRS-1 and inhibits the formation of the IRS-1/p85 complex. 
 
CaMKII is necessary for the negative feedback of insulin-stimulated Akt phosphorylation, Glut-4 translocation and glucose uptake. 
We investigated the effect of CaMKII inhibition on Akt phosphorylation stimulated by insulin (Fig. 7A). CaMKII inhibition had no effect on AKT 
phosphorylation induced by 15 min of insulin stimulation. After 30 min of insulin stimulation, Akt was no more phosphorylated, whereas the phosphorylation 
was maintained by KN93 in a dose-dependent manner and was stimulated at higher KN93 concentrations. We then determined the effect of CaMKII inhibition 
on Glut-4 translocation induced by insulin (Fig. 7B). Glut-4 translocation to the cell membrane was observed by 30 min of insulin treatment, and it remained 
constant up to 60 min. By 120 min, membrane Glut-4 was minimal. CaMKII inhibition maintained Glut-4 in the membrane up to 120 min. The effect of 
CaMKII inhibition on insulin-induced glucose uptake was also determined. The cells were stimulated with insulin for the indicated time with or without 30 min 
KN93 pre-treatment. [14C]2-D-glucose was added to the cells for the last 10 min of stimulation and the radioactivity determined (Fig. 7C). Glucose uptake was 
stimulated by insulin, and it returned to the basal level by 120 min. KN93 increased basal glucose uptake and, as predicted by the observation of the sustained 
Akt phosphorylation and Glut-4 in the membrane, CaMKII inhibition increased glucose uptake that lasted up to 120 min. 
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DISCUSSION 
 
The results of this study demonstrate that activation of insulin receptor generates three interplaying signaling systems that regulate cell growth and glucose 
uptake (Fig. 9). 
The role of Ca2+ in insulin signaling has been investigated in different studies with different approaches. While some studies suggest that Ca2+ is involved in 
insulin signaling in several cell types (29-31), others failed to demonstrate that insulin modifies [Ca2+]i (32-34). Klip et al. found that insulin did not induce 
[Ca2+]i increase in L6 cells (35). However, the low sensitivity of the Ca2+-indicator Quin-2 used in that study bias their results and raises doubts on their 
conclusions. Partly according to Klip observations, a more recent study employing Indo-1 in single mouse muscle fibers suggested that insulin increases near-
membrane Ca2+ concentration, while global myoplasmic [Ca2+]i does not significantly change (14). In an other study, insulin induced a very fast (2 sec) and 
transient [Ca2+]i increase in rat myotubes (36). Our results demonstrate that insulin induces a slow and global [Ca2+]i in L6 cells. The discordance between these 
results might be explained by differences in calcium homeostasis between the cell models employed and more importantly by the timing of the observation. Our 
results are not in conflict with previously published results as all the studies mentioned  investigated only the very early insulin effects , whereas in our study we 
examined later effects as our interest was focused on subsequent enzyme activation mediated by Ca2+. In our experiments a very fast global effect on [Ca2+]i 
was not present or was hidden, however a progressive increase of [Ca2+]i was evident after few minutes of insulin stimulation and became maximal by ~25 min. 
The increase of [Ca2+]i (global or restricted at CaMKII location) induced by insulin was of a magnitude sufficient to activate a signaling pathway involving  
CaMKII, a kinase whose activation is dependent by Ca2+. CaMKII activation by insulin was observed in rat soleus muscle but it was not demonstrated in 3T3-
L1 adipocytes  suggesting that the link between insulin and CaMKII may be tissue-dependent (41, 42). 
 
 
We demonstrated that in thyroid cells integrin stimulation by fibronectin, besides activating the Ras→Raf-1→Mek→Erk-1/2 pathway, also 
generates a Ca2+→CaMKII signal that modulates the Ras→Erk pathway (18, 21). In thyroid cells, CaMKII is activated by integrin engagement and binds to 
Raf-1, participating with Ras to its activation. In the present study, the observation that CaMKII inhibitors completely abolished Erk-1/2 phosphorylation as 
well as [3H]thymidine incorporation induced by insulin stimulation, demonstrate that in our model of rat muscle cells Erk-1/2 activation requires active 
CaMKII. These results were reproduced also in human fibroblasts, where CaMKII inhibition achieved by y dominant-negative CaMKII expression 
demonstrated the pivotal role of this kinase in the insulin signal that leads to Erk-1/2 activation (manuscript in preparation). These results extend what we 
previously observed, suggesting that the CaMKII/Raf-1 interplay is not a mechanism restricted to integrins in thyroid cells.  
 
The finding that the insulin signaling leading to Erk-1/2 activation is modulated by Ca2+→CaMKII provides new insights into the mechanism of signal 
transduction that allows insulin to exert its pleiotropic effects. Glucose production by the liver and glucose uptake in certain tissues, such as fat, fibroblasts and 
muscle, depend upon insulin. At the same time, insulin also stimulates cell proliferation. Metabolic and mitogenic responses to insulin are paired in cell 
cultures, however in vivo the prevalence of one effect on the other may be more appropriated depending upon cell type, variations of environmental conditions 
or to maintain systemic homeostasis. Prior studies have indicated that phosphorylation of IRS-1 at S612 by Erk-1/2 inhibits IRS-1/PI3-K binding and in turn 
Akt activation, thus generating a negative feedback loop regulating some of insulin effects. In  L6 mytubes, both IRS-1 and IRS-2 are responsible of Erk-1/2 
activation stimulated by insulin, whereas only IRS-1 phosphorylates Akt1 and is responsible of Glut-4 translocation and glucose uptake (43). In the liver, the 
major site for glucose production and storage, this mechanism regulates glucose metabolism and finally influences the glycemia (44). Liver knockout Gab1 
mice demonstrated that mitogenic and metabolic effects can be dissociated by interfering with one component of the Erk-1/2 kinase cascade. By inhibiting Erk-
1/2 activity, the cell might selectively increase the strength of the metabolic effects induced by insulin, and increased glucose uptake can be obtained only 
where required without increasing insulin secretion and generalized systemic effects. Because several are the factors that modify [Ca2+]i, this might represent a 
site where different effectors converge to modulate insulin signaling.  
 
The involvement of Ca2+ in insulin-stimulated glucose transport has long been debated, and a large body of evidence associates [Ca2+]i variation with 
modulation of glucose transport. Ca2+ channel blockers such as nifedipine, or the calmodulin inhibitor W7, reduced insulin-stimulated glucose transport in 
skeletal muscle cells (29, 45, 46). Recently, an other study proposed in 3T3-L1 adipocytes a permissive role for CaMKII in the insulin-stimulated glucose 
transport through a mechanism not involving Glut-4 translocation (42). However, other disaccording results raised the possibility that Ca2+ might have biphasic 
effects on insulin-stimulated glucose transport, depending on the magnitude of [Ca2+]i variations, i.e. ionomycin increased [Ca2+]i and inhibited insulin-
stimulated glucose transport in skeletal muscle cells {Lee, 1995 #417}.  
The disaccording results obtained to date are probably the consequence of Ca2+/CaMKII effects exerted at multiple sites and at different time. Our results are 
not in conflict with the positive role of CaMKII proposed in some studies. All these studies investigated the role of Ca2+ signaling at 30 min of insulin 
stimulation, while we focused our attention on the following negative feedback loop involving the Erk/IRS-1 interplay. Thus, in the model we propose, the 
Ca2+/CaMKII signaling mediates both the early insulin-stimulated glucose up-take as well as its following down-regulation. 
In this model, CaMKII is a pivotal kinase in both metabolic and mitogenic signals of insulin and its role in some insulin involving pathologies should be 
considered. 
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Several evidences support the increase of Erk-1/2 activation and the reduction of IRS-1/2 tyrosine phosphorylation and association with PI3-K in patients with 
type 2 diabetes (48). CaMKII might have a role in the pathogenesis of insulin resistance by modulating the insulin signal that leads to Erk-1/2 and in turn to Akt 
activation. The contribution of CaMKII to these changes in insulin receptor function is worthy to be further investigated.  
The identification of a novel molecular mechanisms involved in the modulation of insulin signaling and glucose metabolism provides new targets for 
pharmacological interference: CaMKII might represent another novel therapeutic target offering new insights to the treatment of hyperglycemia. 
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FIGURE LEGENDS 
 
Figure 1. Time course of insulin induced signalings. L6 rat muscle cells were starved overnight from serum. A the cells were 
stimulated with 100 nM insulin for 5 to 120 min and cell lysates were analyzed by Western blot with total or phospho-specific 
(p-) antibodies to Akt,  Erk-1/2 or CaMKII. For the latter, we used the specific antibody recognizing the phosphorylated T286 
of the activated kinase. Averages of relative expressions of phosphorylated kinases were also determined by scanning 
densitometry of three immunoblots. In each diagram, a value of 1 O.D. arbitrary unit was assigned to the 0 point. B, the cells 
were stimulated for 15 or 30 min with the indicated nM insulin concentration, and phosphorylated Akt determined by Western 
blot. Averages and S.D. of relative expressions of pAkt were determined as before. Variations of pAkt at 30 min were not 
significant. 
 
Figure 2. Insulin induces [Ca2+]i increase. A, the cells were starved from serum and loaded with Fura-2. Then, the cells were 
resuspended by tripsinization and [Ca2+]i was measured by a fluorimeter for 15 min before insulin stimulation (arrow) and for 
the following 15 min. Insulin concentrations were: 1 mM, empty circle, dotted line; 10 nM empty circles continuous line; 100 
mM full circles. B and C, the cells grown onto glass coverslips were loaded with Oregon green, stimulated with 100mM 
insulin and observed by confocal microscopy as described in Materials and Methods. [Ca2+]i is reported Relative fluorescence 
= (fluorescence – fluorescence at 0 point)/ fluorescence at 0 point) 
 
Figure 3. Insulin induces CaMKII activation. The cells were starved from serum and stimulated with insulin at the indicated 
nM concentrations. Panel A, cell lysates were analyzed by Western blot with antibodies to total CaMKII or to phosphorylated 
T286-CaMKII (p-CaMKII). Averages and S.D. of relative expressions of pCaMKII were also determined by scanning 
densitometry of three immunoblots. A value of 1 O.D. arbitrary unit was assigned to the point 0. Panel B, The cells were 
stimulated for 30 min with 100 nM insulin and total CaMKII was immunoprecipitated with a specific antibody. CaMKII 
activity was measured by a phosphorylation assay of the CaMKII peptide substrate autocamtide. The results are presented as 
total incorporated cpm. Data are reported as the mean +/- standard deviation from quadruplicate experimental points. BSA 
versus Insulin, p < 0.001. 
 
Figure 4. Insulin stimulates CaMKII association with Raf-1. The cells were serum starved and stimulated with 100 nM insulin 
for 30 min in the presence of 10 μM KN93, or 5 nM antCaNtide. The cell extracts were immunoprecipitated with a specific 
anti-CaMKII antibody or an unrelated monoclonal antibody (ctrl-IgG). After protein separation by SDS-PAGE and transfer to 
a nitrocellulose membrane, immunoprecipitated CaMKII and coprecipitated Raf-1 was detected by specific antibodies. IP, 
immunoprecipitation; WB, Western blot.  
 
Figure 5. CaMKII is necessary to insulin-dependent Erk-1/2 phosphorylation and DNA synthesis. Panel A, serum-starved cells 
were stimulated for 30 min with 100 nM insulin. The cells were treated with KN93 at indicated μM concentrations or with 5 
nM ant-CaNtide or R-ant-CaNtide. Averages and S.D. of relative expressions of phosphorylated Erk were also determined by 
scanning densitometry of independent immunoblots. A value of 1 O.D. arbitrary unit was assigned to the minor point. Panel B, 
2x105 cells were plated in 24-well plates, and serum-starved for 48 hours. [3H]thymidine and 100 nM insulin were then added 
to the plates. After 24 h the plates were washed and insoluble TCA radioactivity counted by scintillation fluid in a β-counter. 
KN93 (10 μM) or antCaNtide (5 μM) were added where indicated. Data are reported as mean ± SD of quadruplicate 
experiments. *, significant vs. CTRL point. **, significant vs. insulin alone. 
 
Figure 6. CaMKII inhibition preserves insulin-stimulated IRS-1/p85 complex and abrogates IRS-1  phosphorylation on S612. 
Panel A, the cells were pre-treated with 5 μM KN93 for 30 min and stimulated with 100 nM insulin for the indicated time. 
IRS-1 was immunoprecipitated from cell extracts and after protein separation by SDS-PAGE and transfer to a nitrocellulose 
membrane, immunoprecipitated IRS-1 and coprecipitated p85 subunit of PI3K were detected by specific antibodies. Panel B, 
the cell were treated as before, IRS-1 was immunoprecipitated from cell extracts and analyzed by Western blot with antibodies 
to phosphorylated-Ser612-IRS-1 (pS612) or total IRS-1. In both panels, averages and S.D. of relative expressions of 
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coimmunoprecipitated p85 or phosphorylated-S612-IRS-1 were also determined by scanning densitometry of independent 
immunoblots. A value of 1 O.D. arbitrary unit was assigned to the minor point. 
 
Figure 7. CaMKII inhibition abrogates the down-regulation of insulin-stimulated Akt phosphorylation,  Glu-4 membrane 
translocation and glucose uptake. Panel A, Phosphorylated and total Akt were visualized by Western blot in cells treated with 
insulin for 15 or 30 min and pretreated for 30 min with increasing μM concentration of KN93. Panel B, Cell membrane 
extracts were prepared as described in Material and Methods from cells treated for 30 or 120 min with 100 nM insulin with or 
without 5 nM antCaNtide (ant). Glut-4 and insulin receptor beta chain (IRbeta, used as a membrane marker) were determined 
by Western Blot. Panel C, the cells were stimulated with insulin with or without 10 μm KN93 for the indicated time and 
[14C]2-D-glucose was added to the medium in the last 10 min. Then, 2-D-glucose uptake was determined. Data are reported as 
mean ± SD of 3 independent experiments in triplicates. *, significant vs. insulin alone. 
 
Figure 8. A schematic time course of insulin signaling. Diagrams are a schematic representation of time-dependent insulin-
stimulated Erk, Akt and CaMKII activation, increase of [Ca2+]i, S612-IRS1 phosphorylation, IRS1/p85 interaction, Glut-4 
translocation to the membrane and glucose uptake. The diagrams are only indicative of time variations and are not quantitative. 
 
Figure 9. Schematic diagram of the insulin receptor signaling in L6 cells. Activation of the insulin receptor generates the IRS-
1/2→PI3-K→Akt signaling pathway and promotes glucose uptake. Insulin receptor activation generates two other signals: 
[Ca2+]i→CaMKII and IRS-1/2→Erk-1/2. They both participate to Raf-1 activation, leading to stimulation of cell proliferation. 
Activated Erk-1/2 phosphorylates S612-IRS-1 and inhibits its association with PI3-K and in turn Akt activation, thus 
generating a negative feedback loop that down-regulates insulin stimulated glucose uptake. Abbreviations: IR, insulin receptor; 
IRS, insulin receptor substrate; Erk, extracellular regulated kinase; PI3-K, phosphatydidlinositol 3-kinase; Akt, protein kinase 
B; CaMKII, calcium-calmodulin dependent kinase II. 
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